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ABSTRACT 
Mammalian orthoreoviruses (MRV) are non-fusogenic, nonenveloped, icosahedral, 
RNA viruses, containing a 10-segmented double-stranded RNA genome, belonging to the 
family Reoviridae. Infection with many mammalian orthoreovirus (MRV) strains results in 
shutoff of host, but not viral, protein synthesis via protein kinase R (PKR) activation and 
phosphorylation of translation initiation factor eIF2 . When cells are under stressful 
environments, such as heat shock, oxidative stress, nutritional starvation, and viral infection, 
several kinases (PKR, PERK, HRI, or GCN) are activated, which phosphorylate 
eIF2 ser), resulting in the formation of stress granules (SGs), discrete areas in the 
cytoplasm where cellular mRNAs are held in a translationally inactive state. We examined 
MRV-infected cells to characterize SG formation in response to MRV infection.  We found 
SGs formed at early times following infection (2-6 h p.i.) in a manner dependent on 
phosphorylation of eIF2 . MRV induced SG formation in all four eIF2  kinase knockout 
cell lines, suggesting at least two kinases are involved in induction of SGs. Inhibitors of 
MRV disassembly prevented MRV-induced SG formation, indicating that viral uncoating is a 
required step for SG formation. Inactivation of MRV virions by ultraviolet (UV) light, or 
treatment of MRV-infected cells with the translational inhibitor, puromycin, did not prevent 
SG formation, suggesting that viral transcription and translation are not required for SG 
formation. Viral cores were found to colocalize with SGs, however, cores from UV-
inactivated virions did not associate with SGs, suggesting viral core particles are recruited 
into SGs in a process that requires the synthesis of viral mRNA. These results demonstrate 
that MRV particles induce SGs in a step following viral disassembly but preceding viral 
mRNA transcription, and that core particles are themselves recruited to SGs, suggesting the 
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cellular stress response may play an inhibitory role in viral translation. 
As infection proceeds, MRV disrupts SGs despite sustained levels of phosphorylated 
eIF2 , and further, interferes with the induction of SGs by other stress inducers. MRV 
interference with SG formation occurs downstream of eIF2α phosphorylation suggesting the 
virus uncouples the cellular stress signaling machinery from SG formation. We additionally 
examined mRNA translation in the presence of SGs induced by eIF2α phosphorylation 
dependent and independent mechanisms. We found that irrespective of eIF2α 
phosphorylation status, the presence of SGs in cells correlated with inhibition of viral and 
cellular translation.  In contrast, MRV disruption of SGs correlated with release of viral 
mRNAs from translational inhibition, even in the presence of phosphorylated eIF2α.  Viral 
mRNAs were also translated in the presence of phosphorylated eIF2α in PKR-/- cells.  These 
results suggest that MRV escape from host cell translational shutoff correlates with virus-
induced SG disruption, and occurs in the presence of phosphorylated eIF2α in a PKR 
independent manner.  
In order to escape from host cell translational shutoff induced by eIF2  
phosphorylation, MRV must use a translational strategy different from that used by most 
cellular mRNA. We have recapitulated a 10-plasmid-based reverse genetics system in our lab 
and have established inducible viral protein-expressing cell lines to examine whether unique 
genomic sequences in the viral mRNA, or alternatively, virally encoded proteins, play a 
critical role in viral translation at late times in MRV infection. Taken together, these studies 
have added significantly to our knowledge on viral-host interactions and regulation of viral 
translation in members of the Reoviridae family, and further, have laid the groundwork for 
important studies examining the mechanisms of tumor oncolysis by MRV.
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
 
Mammalian orthoreovirus (MRV) is a genus of reoviridae family that can infect all 
mammalian species, but is generally non-pathogenic to immune-competent humans or other 
animals that it infects (5).  However, MRV is a potent and specific oncolytic agent that 
selectively kills ras-activated tumor cells over normal cells (9). MRV is also an ideal virus 
for the study of injury-induced encephalitis in the mouse model because the viral replication 
cycle has been thoroughly studied and can be dissected with different inhibitors (3). Infection 
of cells with MRV activates protein kinase R (PKR) and induces phosphorylation of the 
eukaryotic translation initiation factor eIF2 alpha subunit at the active site serine at amino-
acid position 51 (6). eIF2  is a major component of ternary complexes (eIF2-GTP-tRNAi
Met
) 
which bind to the cellular 40S ribosome for the purpose of delivering the initiating 
methionine of nascent protein synthesis in the canonical model of eukaryotic translation. 
When phosphorylated, eIF2  has about 40 times higher affinity to eIF2B, a nucleotide 
exchange factor that normally serves to exchange GDP for GTP to reload ternary complex 
for a new round of translation.  This increased affinity prevents nucleotide exchange and 
results in inhibition of ternary complex formation and subsequent translation initiation [in the 
review (1)].  Though most cellular translation is shutoff as a result of MRV-induced eIF2  
phosphorylation, viral mRNA translation is unaffected (8).  In recent work, 
eIF2 phosphorylation was also found to be sufficient to trigger the formation of distinct 
structures in stressed cells called stress granules (4). Stress granules are dynamic non-
membranous cytoplasmic matrices, which sequester stalled 43S translation initiation 
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complexes containing cellular mRNA and associated translation initiation factors and 
ribosomal proteins together with RNA binding proteins TIAR, TIA-1, and G3BP (2, 10). 
Stress granules are thought to reprogram cellular translation and only allow stress response 
proteins to be translated when cells are under stress (11). A previous study found that MRV 
infection induces SGs at late times post-infection, suggesting that these structures might be 
related to host cellular translational shutoff following infection (7).  
In our studies, we further examined the relationship between MRV infection and SG 
formation throughout infection by performing time-course experiments. We found that MRV 
infection induces SGs at early times post-infection in an eIF2 phosphorylation-dependent 
manner, at a step following virus uncoating and preceding viral transcription and translation. 
We additionally found that as infection proceeds and viral proteins accumulate, MRV 
interferes with SG formation at a step downstream of eIF2  phosphorylation. In order to 
understand the physiological impact of SGs on viral translation, we developed a new protein 
labeling technology to visualize protein synthesis in the presence and absence of SGs. We 
found viral translation correlates with SG disruption, regardless of the status of eIF2  
phosphorylation and independent of PKR.  These findings show, for the first time, that MRV 
induction of and escape from cellular translational shutoff are independent mechanisms.  
They also show that while MRV induction of host cell translational shutoff is PKR 
dependent, MRV escape from shutoff is PKR independent, and in fact, occurs in the presence 
of high levels of phosphorylated eIF2 . The question of how viral translation occurs in the 
global cellular environment of limited ternary complex that occurs in the presence of 
phosphorylated eIF2  has yet to be determined. In order to begin to answer this question, we 
have established a recently reported 10-plasmid-based reverse genetics system for MRV, as 
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well as created inducible cell lines expressing each MRV protein.  These important reagents 
will allow us to test our hypotheses that specific viral RNA sequences or viral proteins play a 
role in MRV escape from host cell translational shutoff. This research has expanded our 
knowledge of the function of SGs in viral infection, the viral translation strategies in the host 
shutoff environment, and has laid important groundwork for future studies aimed at 
identifying mechanisms behind the oncolytic properties of MRV. 
Dissertation organization 
 
This dissertation includes an abstract and six chapters. The abstract describes findings in my 
research and my thoughts towards future study. Chapter 1 is a general introduction for the 
projects I worked on during my graduate study toward the Degree of Philosophy. Chapter 2 
contains a literature review that describes some aspects related to my research projects. 
Chapter 3 was published in the Journal of Virology in 2009. Chapter 4 is prepared for 
publication. Chapter 5 describes a new strategy I have developed for future studies on my 
research project and will be included in a future publication. Chapter 6 is a general 
conclusion that describes where this research is leading and how it impacts other fields. At 
the end of chapter 2, 3, 4, and 5 are references, tables, figures and legends.  
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CHAPTER 2. A REVIEW OF MAMMALIAN ORTHOREOVIRUS PROPERTIES, 
VIRAL INFECTION, CELLULAR STRESS RESPONSE, AND VIRAL ONCOLYSIS 
 
Introduction and significance 
       The non-fusogenic mammalian orthoreoviruses (MRV) are members of the family 
Reoviridae, which contains 9 genera that are classified according to structural similarity 
(spherical icosahedrons), nucleic acid type and composition (10-12 segmented double-
stranded RNA), and replicative strategies. Viruses from this family infect a wide range of 
hosts including human, animals, plants, insects, and fish (49). Some are very important 
human, animal, and plant pathogens, such as rotaviruses which are the leading worldwide 
pathogen causing acute gastroenteritis in infants and young children, bluetongue viruses 
which cause serious hemorrhagic disease in livestock (sheep, goats, and cattle), and 
fijiviruses which cause significant crop failure and economic loss in rice and maize.  
Mammalian orthoreovirus encloses a 10-segmented double-stranded RNA (dsRNA) 
genome within a non-enveloped, multilayered, icosahedral protein capsid (97). A growing 
amount of evidence suggests that MRV is a potent and specific oncolytic agent which 
preferentially kills ras-activated tumor cells over normal cells (124). Ras is member of a 
family of genes encoding small GTPases that are involved in cellular signal transduction. 
Deregulation of Ras signaling can ultimately lead to oncogenesis and cancer (86, 124). 
Studies have shown promising data suggesting reovirus selectively kills human colon cancer, 
ovarian cancer (56), breast cancer (99), pancreatic cancer (48), metastatic tumors (3), and 
glioma (117, 134). Reovirus has the potential to replicate in 80% of cancer cell types, as most 
tumor cells possess an activated ras-pathway (33, 86). Viral uncoating, translation of viral 
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mRNA, and virus-induced apoptosis is enhanced in ras-activated tumor cells (87). However, 
the precise mechanism of oncolysis by MRV is not clearly established. Research on virus-
cell interactions, viral RNA replication, and translation will enhance our understanding of the 
mechanism by which reovirus selectively replicates in these tumor cells, and will further 
expand our knowledge on the basic transcription, translation, and replication strategies of this 
important viral family.  
Mammalian orthoreovirus properties 
 
Structure of virions, subviral particles (ISVPs), and viral cores 
       Mature reovirus particles, or virions, are environmentally stable, enclosing the ten-
segmented dsRNA genome within an icosohedral structure consisting of eight proteins (45). 
The dsRNAs are protected not only by a densely packed core shell primarily formed by 1 
and 2, but also by an outer capsid formed by tight 3- 1, 2- 3, and 2- 1 interactions. 
Virions (850 Å in diameter) can be converted into two distinct types of subviral particles, 
intermediate subviral particles (ISVPs) (800 Å in diameter), or cores (600 Å in diameter) 
(Fig. 1A) through the cleavage of outer capsid proteins by trypsin or chymotrypsin in vitro 
(23, 45) and cellular proteases (cathepsin L, and B) in vivo (9, 46). During natural infection, 
virions attach to cell surface receptors, enter cells through receptor-mediated endocytosis into 
the endosome where virions are transformed into ISVPs through the cleavage of 3 and 1 
by proteases (cathepsin L and B) (Fig 1A) (46). ISVPs can then further penetrate endosomal 
membranes through pores formed by the cleaved N terminal domain of 1 (1, 137), and 
further transform into core particles which do not have outermost capsid proteins ( 3 and 1) 
(Fig 1A). Core particles are released into the cytoplasm, and do not further disassemble. Core 
particles are able to transcribe viral RNA in vivo and in vitro (12, 79).  
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ISVPs have lost the outermost capsid protein 3, but maintain a cleaved version of 
outer capsid protein and retain infectivity . Cores lose all outer capsid 
proteins, ( 3 and receptor binding protein 1), and also lose the ability to penetrate cell 
membranes and infect cells. Transfecting cores directly into cells with tranfection reagents 
(eg. Lipofectamine) can generate new infectious virus (60). All three reovirus particle types 
have distinct morphologies that can be visualized by negative-stain electron microscopy and 
cryoelectron micrographs. Virions appear roughly spheroidal, with smooth perimeters; ISVPs 
appear even more spheroidal than virions, with long fibers ( 1) extending from surfaces; and 
cores have prominent spikes ( 2) protruding from their surfaces at axes of fivefold symmetry 
(98).    
Components of viral particles 
 
Outermost capsid proteins 
       Structural proteins 1 and 3 (at a ratio of 1:1) form the lattice of the outer capsid of 
virions. 3 and 1 bind to each other to stabilize the capsid structure (98). The 1 protein is 
organized in trimeric complexes within virions and forms heterohexamers with 3 (Fig. 1B).  
3 covers 1 to prevent it from interacting with the cellular membrane (Fig 1A, B). Adhesin 
1, in the form of trimers seen as a long fiber (40 nm) protruding from the 12 vertices of the 
icosahedral virion (Fig 1A), plays a role in cell attachment. The crystal structure of 1 
reveals an elongated trimer with a compact head consisting of a beta-barrel fold which binds 
to the junction adhesion molecule 1 (JAM1) receptor on the cell surface, and a fibrous tail 
containing a triple beta-spiral which in turn plays a role in forming a trimer (Fig 1C) (26). 
Four positions between residues 415 and 447 contribute to forming the receptor-binding head 
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domain across the interface between two subunits. Antigen-specific immunoglobulin A or G 
binding to this receptor-binding domain prevents infection (55).   
Following viral entry through receptor mediated-endocytosis, 3 is cleaved by a 
variety of proteases including cathepsin L, which is an important step in viral disassembly. 
Two regions are hypersensitive to proteases at early steps of this processing. Carboxyl-
proximal residues within 3 are primary determinants of strain difference in viral entry, 
determining the rate at which early cleavage occurs. This indicates that proteolytic 
processing of 3 during viral disassembly is a multi-step pathway (59). Cleavage of 3 
exposes the membrane penetration protein 1 to endosomal membranes. Autolytic cleavage 
of 1 divides it into myristoylated 1N and 1C. Dissociation of 1N triggers a major 
conformational change of the entire 1 trimer (24, 80). The myristoylated 1N inserts and 
generates holes in the endosomal membrane to release viral core particles into cytoplasm (1, 
57).  
Inner capsid proteins       
 Inner capsid (core) proteins 1 and 2 form the primary icosahedral lattice of the 
inner capsid. 2 (mRNA capping guanylytransferase and methyltransferase) protrudes and 
forms turrets from the surfaces of the core shell around each fivefold axis (20, 84).  3 and 
2 (RNA-dependent RNA polymerase and putative polymerase cofactor) are located within 
the cage formed by 1 and 2 near the five axes (66, 125). 1 and 2 are expected to contact 
genomic RNA since both proteins can bind to double stranded RNA (43, 77). The 10 dsRNA 
genomic segments serve as templates for mRNA synthesis by the viral transcriptase ( 3) 
within the core. Each copy of 3 anchors to the inner surface of the icosahedral core shell, 
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and primarily contacts three molecules of shell protein 1 and overlaps with a five-fold axis. 
Thus one copy of 3 is bound per vertex, transcribes viral RNA, and orients nascent RNA to 
pass into the large external cavity of the pentameric capping enzyme complex formed by the 
protein 2 (125, 138). 2 is a divalent cation-dependent nucleoside triphosphatase that can 
remove the 5' -phosphate from RNA. 2 interacts with the RNA-dependent RNA 
polymerase ( 3) in vitro, and the presence of 3 mildly stimulates the triphosphatase 
activities of 2 (66). 2 forms a hollow cylinder which sequesters mRNA to ensure 
completion of the capping reaction (108) which is performed by the methyl- and guanylyl-
transferase activities of the 2 protein (20, 31, 85).  
Once cap structures (
m7GpppGpC) are added at the 5’ termini of the newly 
synthesized positive (+) RNA, the new viral mRNAs are released into the cytoplasm for 
translation of viral proteins. The newly synthesized inner core proteins ( 1, 2, 3, 2, 2) 
assemble into progeny core particles, and during this process, viral mRNAs serve as 
templates for the synthesis of progeny dsRNA. The newly assembled core particles can also 
synthesize mRNA for later translation. At some point, the core particles are further coated 
with three remaining viral outer capsid proteins ( 1, 1 and 3) to produce infectious 
progeny virions (98). The regulation of virion assembly is not well understood. 
Viral entry 
       MRV infection begins with the attachment to a cell surface receptor junction adhesion 
molecule 1 (JAM-1) by the 1 protein that extends as a homotrimer from the 12 five-fold 
axes of the virion (14). -2-3-linked sialic acid conjugated to glycoproteins on the surface of 
M cells serves as a coreceptor for 1 attachment (13, 25). 1 is one of the determinants of 
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viral infectivity and tissue tropism (50). Following attachment, virions are internalized via 
receptor-mediated endocytosis (Fig 2). While the virions are within the acidic environment of 
the endocytic vesicles, the outer capsid protein 3, in a heterohexameric complex with 1, is 
proteolytically cleaved from the virion to generate ISVPs. Ammonium chloride (22) and E-
64 (8) can prevent this transformation by either increasing the pH of endosomes to prevent 
protease digestion or directly inhibiting proteases. ISVPs, which contain cleaved 1 as the 
primary outer surface protein, are then transformed into an additional particle type, the 
ISVP*, which results in the production of a hydrophobic conformer of 1.  During this 
transformation, 1 undergoes a conformational change, the 1 protein is released from the 
particle, and core particles are released into the cytoplasm (54). The ISVP to ISVP* 
transition is a necessary and transient step for membrane penetration and release of the 
transcriptionally active core particle into the cytoplasm (24). 
Viral transcription and translation 
       After core particles are released into the cytosol, positive-sense RNA [(+) RNA] is 
transcribed from negative-sense genomic RNA [(-) RNA] in a 5’ to 3’ direction by the 3 
RNA-dependent RNA polymerase and transcriptase cofactor 2 from within the parental core 
particles (125). 2 has nucleoside triphosphatase activity that can remove the 5' gamma-
phosphate from RNA (66). Newly synthesized 5’ termini are moved through the turret-like 
structures formed by 2 located near the five-fold axes of cores where newly transcribed 
RNAs are capped by enzymatic activities of 2 (123, 138) and released into the cytoplasm. 
Reovirus mRNAs are not polyadenylated (11). Eukaryotic mRNAs have 5’ terminal cap 
structures and 3’ terminal poly (A) tails which bind to cap binding protein eIF4E (translational 
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initiation factor 4E) and poly (A) binding protein (PABP). Translation initiation factor eIF4G 
binds to eIF4E and PABP to form eIF4F complex, which circularizes mRNA. eIF4G acts as a 
scaffold to stabilize eukaryotic mRNA and recruit other translational initiation factors and 
ribosomal proteins for forming translation initiation complex in the cytoplasm [reviewed 
(132)]. The related Reoviridae family virus, rotavirus encodes a protein, NSP3, that can bind 
to 3’ termini of rotavirus mRNA and interact with eIF4G, probably playing a role in 
circularizing mRNA and stabilizing viral mRNA (42, 53, 106). NSP3 binding to eIF4G evicts 
polyA binding protein from cellular mRNA, suggesting NSP3 plays a role in host translational 
shutoff (96, 101, 105). However, knockout of NSP3 does not reduce viral translation (95), 
suggesting NSP3 binding to viral mRNA probably is not important for viral translation. So far 
no MRV counterpart of NSP3 has been reported, and how reovirus mRNA is stabilized and 
translated in the cytoplasm has not been determined.  
Secondary, or “late” viral mRNA transcription, represents transcription by progeny 
subviral particles. Zarbl et al proposed that mRNAs synthesized at late time post-infection are 
uncapped, and hypothesized that the capping enzyme ( 2) on progeny core particles is 
blocked by outer capsid proteins (136). Because reovirus infection induces the cell to shutoff 
translation, this hypothesis was used to explain how viral mRNAs, by virtue of being 
uncapped, are preferentially translated in infected cells during host translation shutoff (78).  
However, because structural data suggest genomic RNAs are capped (44), it is unlikely that 
uncapped mRNAs are packaged into progeny particles to serve as a template for negative-
sense RNA synthesis. For this reason, whether all reovirus mRNAs are capped, or whether 
some mechanism exists to produce uncapped mRNAs during reovirus infection remains 
controversial.  
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The translation of individual reovirus transcripts is variable; nucleotide sequences of 
reovirus mRNAs at the -3 and +4 positions flanking the initiator AUG (Kozak sequence) and 
the length of 5’ terminal untranslational regions (UTR) contribute to differing translation 
efficiencies in vitro (71-74) so that viral protein synthesized is proportional to the needs for 
the assembly of virions.  
Viral genomic RNA replication and viral assembly 
      Neither dsRNA or negative-sense RNA is found free in the cytoplasm, suggesting that the 
synthesis of complementary minus-strand RNA occurs either during the core assembly 
process or within assembled core particles (98). Some nucleotides in the 5’ and 3’ termini of 
the 10 genomic segments are conserved among strains of different serotypes (T1L, T2J, and 
T3D) as follows, 5’-GCTA……….TCATC-3’, suggesting they serve as signals for genomic 
RNA assembly (103). The presence of three nucleotides, A-U-U, at positions 79-81 of the S2 
gene are essential for the incorporation of in vitro-generated ssRNAs into new reovirus 
progeny viral particles (110). A minimum of 98 nucleotides at the 3’ terminus is required for 
S2 genome packaging (111).  The 5’ and 3’ termini of M1 and L1 genes were also 
demonstrated to be important for genome packaging (112, 113). The assembly of the 
positive-sense RNA complements of MRV genome segments into cores (RNA assortment) 
occurs at the level of positive-sense RNA, and is thought to be a selective process for a 
number of reasons: i) the central cavity of the viral core cannot accommodate much more 
than the 10 unique genome segments, ii) all 10 of the segments must be present for the virus 
to be infectious, and iii) a particle to PFU (plaque forming unit) ratio as low as 1 has been 
reported. The mechanism by which viral (+) RNAs are selected for packaging is only 
beginning to be understood, but likely involves RNA-protein and RNA-RNA interactions. At 
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early times in infection, (+) RNAs representing each of the 10 viral genome segments have 
been isolated from infected cells in complex with the viral proteins NS, NS, and 3, 
suggesting that these proteins may be involved in forming early RNA assortment complexes. 
At later times in infection, core particles that contain viral (+) RNAs can be isolated from 
infected cells, suggesting that one or more of the five core proteins also binds viral (+) 
RNAs. It is unclear at what step in the RNA assortment and core assembly process that the 
ssRNA is replicated to dsRNA.  
Viral factories  
       Viral factories, also called inclusion bodies, were thought to be the places for the 
assembly of reovirus virions as electronic micrographs showed different sizes of viral 
particles (cores, incomplete particles, and complete virions) embedded in these viral factories 
(98). Early during reovirus infection, inclusion structures begin to form throughout the 
cytoplasm. As infection proceeds, these structures grow in size and migrate to the perinuclear 
region of the cell.  In recent years, a number of studies have found that viral factories play 
important roles in regulating viral replication and translation. A key player in forming 
reovirus factories is the non-structural protein NS encoded by the MRV M3 gene. When 
expressed in transfected cells, nonstructural protein NS forms viral factory-like cytoplasmic 
phase-dense globular matrices (19). The carboxyl-proximal domains (amino-acids 471-721) 
including two predicted coiled-coil domains are necessary and sufficient for forming the viral 
factory-like matrix (16). N-terminal regions of NS recruit other viral proteins (structural 
proteins 2, 3, 1, 2, 2, and nonstructural protein NS), as well as intact viral core 
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particles to viral factories (17, 90, 91). NS binding to core particles does not inhibit the 
transcription and capping activities of cores (18).  
NS-formed viral factories colocalize with the cellular microtubule network ( -
tubulin) and viral microtubule associated protein 2. Inhibition of microtubule-formation 
with nocodazole prevents small cytoplasmic factories from coalescing into large perinuclear 
structures (7, 19, 102). Rare reovirus strains form globular viral factories, while most strains 
form filamentous structures. The globular or filamentous morphology of viral factories was 
mapped to the reovirus 2 protein (19, 102). 2 from globular strains is more prone to 
temperature-dependent mis-folding and therefore displays increased aggregation, increased 
levels of ubiquitinated , and decreased association with microtubules (92).  
Knockdown of NS diminishes viral replication, viral translation, and inclusion 
formation. Complementation of NS can restore viral replication, however, if the 
complementing NS protein cannot form viral factories, replication is not restored (69). This 
strongly suggests viral factories play a crucial role in reovirus infection. For rotavirus, 
knockdown of NSP2, a component of viral factories, causes the decrease of positive (+) and 
double stranded RNA synthesis and viral assembly, while knockdown of structural protein 
VP7 has no effect on the synthesis of dsRNA. Immunofluorescence assays show dsRNAs are 
synthesized in viral factories (120). Some cellular proteins, like heat shock protein 70 
(hsp70) and ubiquitin, are also located in viral factories (92). Because of the localization of 
all of the above viral components and cellular proteins within factories, it has long been 
suggested that many of the processes that are key to the successful replication of reovirus 
occur within these structures.  
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MRV infection, the cellular stress response, and shutoff of host protein synthesis  
 
stress granule formation 
       Many types of external stress trigger phosphorylation of the alpha subunit of the 
translation initiation factor eIF2 through the activation of four individual kinases (PKR, 
PERK, HRI, or GCN). eIF2  phosphorylation prevents the formation of ternary complex, 
eIF2-GTP-tRNAi
Met
, leading to the inhibition of translation of most cellular proteins, and a 
buildup of stalled ribosomal complexes (51). A consequence of this buildup is the formation 
of structures in the cytoplasm called stress granules (SGs), which sequester mRNAs and 
translation initiation factors in a translationally inactive state until the cells recover from 
stress or undergo apoptosis (5, 63). In the absence of cellular stress, eIF2  binds to GTP and 
initiator methionyl-tRNA (met-tRNAi), to form a ternary complex which subsequently binds 
to the 40S ribosomal complex to form the 43S preinitiation complex. mRNA bound to an 
additional initiation complex (eIF4F) then binds to the 43S complex to become the 48S 
initiation complex. At a later point in initiation, the eIF2-bound GTP is hydrolyzed to release 
all of the initiation factors from the ribosome that then continues with translation elongation. 
Following this release, the GDP bound to eIF2 must be exchanged for GTP in a reaction that 
is catalyzed by the guanine nucleotide exchange factor, eIF2B. Upon this exchange, eIF2-
GTP can again bind Met-tRNAi to initiate a new round of translation. When the alpha 
subunit of eIF2 is phosphorylated, it changes from a substrate of eIF2B to a competitive 
inhibitor that binds eIF2B with high affinity, inhibiting the exchange of GDP for GTP. There 
is an excess of eIF2 relative to eIF2B in the cell, therefore, very little eIF2  phosphorylation 
results in the lack of initiator methionyl-tRNA (met-tRNAi) and reduced levels of translation 
initiation.  
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       Another consequence of eIF2  phosphorylation is the induction of SGs (Fig 3)[reviewed 
in (4, 62)]. SGs also can be induced through an eIF2  phosphorylation independent pathway. 
For example, drugs that inhibit ribosome recruitment to initiation complexes (NSC119893) 
(94), hippouristinol, pateamine A (82), 15D-PGJ2 (68)) downstream of ternary complex 
recruitment or depletion of translational initiation factors [4B, 4H, or poly (A) binding 
protein] have been shown to induce stress granule formation independent of eIF2  
phosphorylation (94). On the other hand, stabilizing the polysome with emetine can prevent 
SG formation (64).    
       SGs appear to serve as sites of mRNA triage that monitor the cellular environment to 
determine if a cell will undergo a path of repair or apoptosis. A number of proteins have been 
implicated as being important for directing mRNAs and proteins to and from SGs.  The 
related proteins TIA-1 and TIAR, which play important roles in splicing and translational 
regulation (76), have both been implicated in SG formation (65). These proteins consist of 
three N-terminal RNA recognition motifs (RRMs), and a C-terminal prion-related domain 
(PRD). The N-terminal domain binds to several identified motifs, including poly-A, and is 
likely involved in binding the mRNAs that are recruited to SGs under times of stress. The C-
terminal domain is capable of undergoing self-aggregation, and it is this characteristic that is 
thought to modulate SG assembly (52). Increasing the expression of chaperone heat shock 
protein hsp70 expression reduces the aggregation of PRD (65). Genetic knockout of TIA-1 
leads to significantly increased levels of TIAR protein, and vice-versa, suggesting that the 
expression levels of each of these proteins is regulated by the other. Knockout of TIA-1 
impairs, but does not prevent the formation of SGs, suggesting that TIAR plays some role in 
SG formation, but the increase in TIAR protein that results from TIA-1 knockout does not 
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completely compensate for the loss of TIA-1 in this capacity . A third protein, the RasGAP-
associated endoribonuclease, G3BP, a protein that binds Ras and modulates its activity, has 
also been implicated in SG formation in a manner that is regulated by phosphorylation. 
Cellular stresses result in the dephosphorylation of serine 149 in G3BP, allowing this protein 
to assemble in SGs (127). A recent study showed that G3BP interacts with the tubulin 
deacetylase and ubiquitin binding protein, HDAC6, in a manner that is dependent on 
dephosphorylation of G3BP serine 149. Knockout of HDAC6 severely impaires SG 
formation, suggesting that HDAC6 association with G3BP may be required for G3BP and 
TIA-1/R accumulation in SGs (75). The inhibition of the ubiquitin-dependent proteasome 
system (UPS) also induces SG assembly (88). Furthermore, the deacetylase and ubiquitin 
binding domains of HDAC6 were both required for SG formation, supporting previous 
evidence that both the microtubule network and the ubiquitin:proteasome system play some 
role in SG formation and/or regulation.  
Virus infection, protein kinase R, and eIF2  phosphorylation 
       Early studies showed that infection with most reovirus strains inhibits the translation of 
cellular mRNA while maintaining the translation of viral RNA. The innate immune response 
has been implicated in MRV-induced host translational shutoff via activation of the dsRNA 
kinase, PKR. Viral infection can stimulate the secretion of interferon which then signals the 
activation of PKR (10). PKR can also be activated by binding dsRNA, at which point it 
homodimerizes and undergoes autophosphorylation (83). Activated PKR phosphorylates 
serine 51 on the alpha subunit of the cellular translation initiation factor eIF2 (21), which 
prevents the ternary complex eIF2-GTP-tRNAi
Met
 and results in translational inhibition. PKR 
plays an important role in interferon response to viral infection as mice lacking PKR 
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surrender to the lethal infection of vesicular stomatitis virus, and display increased 
susceptibility to influenza virus. Under environmental stress, phosphorylation of eIF2  
inhibits most cellular translation; mRNAs whose expression is required for the response to 
cellular stress escape this inhibition in a variety of ways (118). The highly structured IRES 
(internal ribosome entry site) of Hepatitis C virus has more than 50% based-pair helices 
which leads to significant increase of autophosphorylation of PKR and phosphorylation of 
eIF2 . The activation of PKR inhibits cap-dependent translation but not viral translation 
(135). Internal ribosome-entry sites (IRESs) allow these mRNAs to escape the inhibitory 
effects of phospho-eIF2α in stressed cells, possibly by several mechanisms. For example, 
simian picornavirus recruits tRNAi
Met
 in an eIF2 independent manner (39). Hepatitis C virus 
recruits eIF2 and tRNAi
Met
 separately without forming ternary complex (eIF2-GTP-
tRNAi
Met
), which contributes to evasion of the interferon-induced
 
antiviral response (109, 
126). Third, alphavirus
 
mRNA can also be efficiently translated in the presence of 
phosphorylated
 
eIF2   through GTP-independent  recruitment of Met-tRNAi
Met
 (131).  
At late times post-infection, cellular translation is shut off in cells infected by most 
reovirus strains and viral proteins are the primary translation products (58). Although 
reassortment studies have suggested that the viral structural protein 3 is the determinant of 
this phenotype, the functional differences between 3 from strains that can prevent shutoff of 
host cell translation and those that cannot are not well-defined (15, 81).  3 from all reovirus 
strains is a sequence-independent dsRNA binding protein which can functionally replace 
both vaccinia virus VAI RNA and adenovirus E3L protein, both known to be PKR inhibitors 
(115). It has been suggested that 3 inhibits PKR by binding dsRNA.  In reovirus strains that 
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do not induce host shutoff, it has been suggested that 3 is localized throughout the cell, 
preventing activation of PKR and subsequent shutoff. In strains of reovirus that cannot 
prevent host shutoff, it has been suggested that 3 is primarily localized in or near viral 
factories, therefore translation is predicted to be inhibited by cellular PKR activation in all 
places in the cell, except viral factories (115). How reovirus translation continues in an 
environment of limited ternary complex when eIF2 is phosphorylated is otherwise poorly 
defined. 
Viral infection and stress granule formation 
       Recently, a number of viruses have been shown to have some impact on SG formation 
and disruption, suggesting that SG perturbation may be a common mechanism for a wide 
variety of viruses to combat this aspect of the cellular stress response. Additionally, several 
viruses appear to benefit from their association with SG effecter proteins. The West Nile 
virus 3’ stem loop of negative sense RNA is bound specifically by both TIA-1 and TIAR, 
and this association appears to be beneficial for viral genome synthesis (47).  Although the 
exact function of TIA-1 and TIAR in WNV infection remains unknown, viral dsRNA and the 
non-structural protein NS3 have both been found to associate with the SG effector protein 
TIA-1/R and prevent SG formation. Further, WNV-infection prevents SG formation and also 
progressively prevents SG formation induced by sodium arsenite (89). A member of the 
alphavirus genus, Semliki Forest virus (SFV), has been shown to induce the phosphorylation 
of eIF2  and transient SG formation (89).  In the case of SFV, it has been reported that viral 
replication begins adjacent to SGs, and that SGs near replicating virus are disassembled, a 
process that appears to be concomitant with a switch from cellular to viral RNA translation 
(131). Another member of the alphavirus family, Sindbis virus (SV), also induces eIF2  
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phosphorylation, however, SV 26S subgenomic mRNA can be translated in the presence of 
phosphorylated eIF2 , using a cellular homologue eIF2A instead of eIF2 for translational 
initiation (114).  A further study showed that 26S subgenomic mRNA can also be translated 
using canonical translation initiation out of the context of viral infection, while initiation can 
occur without some initiation factors (eg. eIF4G, eIF2) in the context of viral infection (104). 
Interestingly, Sindbis virus non-structural protein nsp3 has been shown to associate with 
G3BP, an important effecter protein for SG formation, suggesting that this virus may 
additionally interfere with SG formation (35). Poliovirus has also recently been found to 
induce, then disrupt cellular SGs (133). G3BP was shown to be a target for the poliovirus 3C 
protease, which cleaves this effecter protein, preventing the formation of SGs (133). 
Rotavirus, a Reoviridae family member, was also recently found to induce eIF2  
phosphorylation, but disrupt SGs by a mechanism that remains to be determined (96).  A 
previous study suggested reovirus induces SGs at late time post-infection in response to high 
levels of eIF2  phosphorylation, suggesting SGs are a possible mechanism for host shutoff at 
late times post-infection (122).  
Reovirus-induced apoptosis  
 
       Reovirus-induced apoptosis has been thoroughly studied because the presence of 
apoptosis is strongly correlated with virus-induced injury in mouse models. MRV 
disseminates systemically in newborn mice following infection, and causes injury to a variety 
of organs (128, 129). The determinants of reovirus-induced apoptosis have been mapped to S1 
and M2 gene segments by reassortant genetics. S1 and M2 encode cellular receptor binding 
protein  and membrane penetration protein (130)  Incubation of infected cells with anti-
anti- or anti- monoclonal antibodies blocks viral uncoating and therefore prevents 
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apoptosis (34). The presence of protease inhibitor E-64 and ammonium chloride (NH4Cl), 
which prevent viral uncoating, abolishes reovirus induced-apoptosis suggesting viral 
uncoating is essential for reovirus induced apoptosis (41). UV-inactivated reoviruses, which 
can bind and enter cells, but cannot replicate also induce apoptosis, indicating that viral 
binding and/or disassembly but not viral replication is required for apoptosis (27-30).  
       Several pathways are reported to be involved in reovirus-induced apoptosis, depending on 
the cell type or tissue that is infected. In epithelial cells, reovirus-induced apoptosis is initiated 
through activation of cellular transcription factors NF- B and c-JUN and release of tumor 
necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) (29). In neurons, reovirus 
induced apoptosis is mainly initiated through cell death receptors (DR4 and DR5) (40, 41). 
Calpain, a cytosolic cysteine protease, was reported to play an important role in induction of 
apoptosis, and inhibition of calpain protects against reovirus-induced apoptotic myocardial 
injury (70). Furthermore, reovirus-induced apoptosis has also been demonstrated to occur 
through mitochondrial-mediated, caspase-dependent pathways and death receptor pathways 
(37). 
       Some studies have shown JAM-1-independent, antibody-mediated entry of reovirus into 
cells or direct ISVP entry into cells leads to apoptosis, suggesting that attachment protein 1 
is dispensable for reovirus-induced apoptosis (32). Additional studies showed residues 582-
611 within the C-terminal cleavage fragment of expressed 1, or  domain, are sufficient to 
induce apoptosis (36, 38). Mutations at Lys 594 and Ile595 within the  domain of 1 
diminish apoptosis-inducing capacity of ectopically expressed 1, while mutant viruses 
display no growth defect, suggesting 1 plays an essential role in apoptosis. Furthermore, 
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mutant viruses containing these mutations in  produce less histopathologic injury than wild-
type viruses (36).  
Reovirus oncolysis 
 
Reovirus has been studied as an oncolytic agent for some time for at least two reasons: 
(1) in otherwise isogenic cells, ras-transformation leads to susceptibility to reovirus infection 
where non-transformed normal cells are resistant, and (2) reovirus is considered an “ophan” 
virus because it is nonpathogenic to humans (98). However, the mechanism of MRV 
oncolysis is not clearly understood. Inhibiting the Ras/RalGEF/p38 pathway changes host cell 
permissiveness to reovirus, suggesting the Ras/Ral/p38 pathway benefits reovirus replication 
(100). Murine C26 colorectal carcinoma cells contain a mutant KrasD12 gene.  Knockout of 
Kras D12 does not inhibit viral translation and virus yield, but reovirus-induced tumor cell 
apoptosis is completely abrogated as a result of K-ras knockdown, suggesting reovirus-
induced apoptosis underlies the ras dependency of reovirus oncolysis (121). Marcato et al 
(2007) showed Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, 
particle infectivity, and apoptosis-dependent release (87). Many cancer cells also have 
increased expression of beta-catenin. Inducing beta-catenin expression by inhibiting glycogen 
synthase kinase (GSK)-3-beta sensitizes reovirus-induced apoptosis of colon cancer (93).  In a 
clinical trial, reovirus was shown to kill small lung cancer cells when combined with 
chemotherapy drug taxane and other cancer therapeutic agents, and killing of cells was found 
to be due to accelerated apoptosis (116). These findings again suggest that reovirus-induced 
apoptosis is a possible mechanism for reovirus oncolysis. It has also been proposed that in 
untransformed NIH3T3 fibroblast cells activated PKR inhibits viral replication by 
phosphorylating eIF2 , resulting in blockage of viral protein synthesis. In ras-transformed 
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NIH3T3 cells, PKR phosphorylation and activity are impaired by signaling through activated 
ras, allowing viral translation (119, 124).  This suggests viral translation is also important for 
viral oncolysis.  
A recent study showed that cellular ischemia or hypoxia promotes eIF2  
phosphorylation and SG formation(61). Tumor hypoxia is a major obstacle for radiation and 
chemotherapy because hypoxic tumor cells are resistant to apoptosis. The RACK1 protein 
plays a key role in this resistance by functioning as a mediator between the SG-assembly 
survival pathway and the stress-responsive MAPK cell death pathway. Hypoxia induced SGs 
sequester RACK1, which prevents apoptosis induction by X-rays and genotoxic drugs through 
the stress activated p38 and JNK MAPKKK (SAPK) pathways (6). Our data, which shows 
reovirus disrupts SGs late in infection, may suggest that reovirus-induced release of RACK1 
from SGs may contribute to the mechanism of reovirus-induced oncolysis and synergistic 
killing of tumor cells when coupled with chemotherapy. 
       Recently, Prestwich et al (107) found reovirus failed to reduce tumor burden in severe 
combined immunodeficient mice bearing either B16ova or reovirus-sensitive B16tk 
metastases; however, both active reovirus and UV-inactivated reovirus purged the lymph node 
and splenic metastases in C57BL/6 mice by priming the specific antitumor cytotoxic 
lymphocytes, suggesting reovirus mediated oncolysis is not totally dependent on direct viral 
oncolysis or viral replication and immune-mediated anti-tumor activity is also involved in 
oncolysis. Some cell lines (eg. human HT1080 fibrosarcoma cells) are highly resistant to 
reovirus infection and reovirus persistently exists in some cells. Acquisition of resistance to 
reovirus raises a concern for cancer therapy(67), however, persistently infected cells can be 
killed within tumours upon rechallenge with reovirus (2). 
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Fig 1.Structure cartoons for viral proteins. (A) Reconstructed images from Cryo-EM 
pictures. reovirus virion, intermediate subvirion particle (ISVP), core. Bar=20nm. This is 
adapted from Chandran et al (23). (B) Cartoon representations of crystal structures: 
monomer and dimer, monomer and trimer, and hexamer, alpha helices in hot 
pink, beta sheets in yellow, zinc ions in black, and beta-octylglucoside molecule in violet. 
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Images are from Max Nibert  Lab at Harvard University medical school 
(http://nibertlab.med.harvard.edu/gallery). (C) Cartoon representation of crystal structures: 
trimer, each monomer is shown as blue, yellow, and red. This is adapted from Chappell et 
al (26). 
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Fig 2. The replication cycle of MRV. Following viral attachment, viruses enter cells 
through receptor-mediated endocytosis. Viral core particles are released into the cytoplasm 
without further disassembly. Cores transcribe viral mRNA for translation. New viral proteins 
are synthesized in the cytoplasm and form new viral core particles and possibly concurrently 
enclose viral mRNA into the cores for progeny genomic dsRNA synthesis.  Newly assembled 
core particles launch secondary round of mRNA synthesis.  Progeny virions are assembled in 
viral factories and released from by cell lysis.  
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Fig 3. The cellular stress response and stress granule formation. Many types of external 
stress trigger phosphorylation of the alpha subunit of the translation initiation factor eIF2 
through the activation of four individual kinases (PKR, PERK, HRI, or GCN). eIF2α 
phosphorylation prevents the formation of ternary complex (eIF2-GTP-tRNAi
Met
), leading to 
the inhibition of translation of most cellular proteins, and a buildup of stalled ribosomal 
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complexes. A consequence of this buildup is the formation of structures in the cytoplasm 
called stress granules (SGs), which further inhibit protein translation by sequestering mRNAs 
and translation initiation factors in a translationally inactive state until the cells recover from 
stress or undergo apoptosis (2). Three RNA binding proteins (TIAR, TIA-1, and G3BP) are 
thought  to play key roles in stress granule formation. 
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Abstract 
 
Infection with many mammalian orthoreovirus (MRV) strains results in shutoff of host, but 
not viral, protein synthesis via protein kinase R (PKR) activation and phosphorylation of 
translation initiation factor eIF2 . Following inhibition of protein synthesis, cellular mRNAs 
localize to discrete structures in the cytoplasm called stress granules (SGs), where they are 
held in a translationally inactive state. We examined MRV-infected cells to characterize SG 
formation in response to MRV infection.  We found SGs formed at early times following 
infection (2-6 h p.i.) in a manner dependent on phosphorylation of eIF2 . MRV induced SG 
formation in all four eIF2  kinase knockout cell lines, suggesting at least two kinases are 
involved in induction of SGs. Inhibitors of MRV disassembly prevented MRV-induced SG 
formation, indicating that viral uncoating is a required step for SG formation. Inactivation of 
MRV virions by ultraviolet (UV) light, or treatment of MRV-infected cells with the 
translational inhibitor, puromycin, did not prevent SG formation, suggesting that viral 
transcription and translation are not required for SG formation. Viral cores were found to 
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colocalize with SGs, however, cores from UV-inactivated virions did not associate with SGs, 
suggesting viral core particles are recruited into SGs in a process that requires the synthesis 
of viral mRNA. These results demonstrate that MRV particles induce SGs in a step following 
viral disassembly but preceding viral mRNA transcription, and that core particles are 
themselves recruited to SGs, suggesting the cellular stress response may play a role in the 
MRV replication cycle. 
Introduction 
 
The non-fusogenic mammalian orthoreovirus (MRV) is a member of the Reoviridae 
family of segmented double-stranded RNA (dsRNA) viruses. The genome of MRV consists 
of 10 segments of dsRNA contained within a non-enveloped, multi-layered, protein capsid. 
During entry into cells, the outermost MRV capsid layer is removed by endosomal proteases, 
creating intermediate subvirion particles (ISVPs). ISVPs undergo an additional 
conformational change resulting in a particle (ISVP*) that is capable of penetration of the 
endosomal membrane.  Coincident with cellular membrane disruption, the inner capsid, or 
core, is released into the cytoplasm (11). The core particle, which contains the viral 
polymerase, guanylyltransferase, and methyltransferase enzyme activities, transcribes 
mRNAs corresponding to each of the 10 viral genes in the cytoplasm (14, 20). MRV mRNAs 
are unique from cellular mRNAs in that they do not contain a 3  polyA tail, but do have an 
m
7
GpppN cap structure on their 5  end (6). As infection proceeds, distinct viral structures, 
termed viral factories (VFs), form in the cytoplasm primarily through the action of the non-
structural protein, NS, which constitutes the structural matrix of the factories (8, 10). Core 
particles, viral proteins, newly synthesized viral mRNA, and dsRNA are localized within 
VFs, suggesting that transcription, replication, and assembly of progeny viral core particles 
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occur within these structures (7, 8, 10, 35, 36). 
Infection with MRV has been shown to induce phosphorylation of the  subunit of 
the translation initiation factor eIF2 (39, 45, 47, 55), a modification that inhibits host cell 
translation initiation by preventing the formation of ternary complex (eIF2/GTP/tRNAi
Met
) 
[reviewed in (42, 44)]. In the case of MRV infection, phosphorylation of eIF2  is associated 
with the activation of protein kinase R (PKR) (55). PKR activation and subsequent eIF2  
phosphorylation, together with the interferon (IFN) regulated 2',5'-oligoadenylate synthetase 
RNAse L system, are necessary for MRV-induced host cell translation shutoff (48). MRV 
mRNA continues to be translated following shutoff of host cell translation, although the 
mechanism for escape is not well understood. Moreover, studies have indicated that MRV 
replication may benefit from this aspect of the cellular response to infection by 
demonstrating that MRV replication is more efficient in the presence of PKR and 
phosphorylatable eIF2
An additional level of cellular translation regulation has recently been identified. 
Treatment of cells with drugs that inhibit various aspects of protein translation (32, 38), or 
other external stress (such as nutrient starvation, heat shock, oxidative stress, or viral 
infection), that lead to the phosphorylation of eIF2  by specific kinases [PKR, PKR-like 
endoplamic reticulum kinase (PERK), general control non-derepressible kinase (GCN), 
Heme-regulated inhibitor kinase (HRI)], is sufficient to trigger the formation of distinct 
structures in the cytoplasm termed stress granules (SGs) [reviewed in (3, 24)]. SGs sequester 
stalled 43S pre-initiation complexes (including 40S ribosomes, mRNAs, and many 
translation initiation factors) in a translationally inactive complex to hold non-stress related 
cellular translation in check. Once the stress is removed, SGs are disassembled and the 
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translational material is released for reuse [reviewed in (24)]. The translational silencing 
proteins, T cell intracellular antigen 1 (TIA-1) and TIA-1 related protein (TIAR) play a role 
in SG aggregation. These proteins contain three N-terminal RNA recognition motifs (RRM), 
and a C-terminal domain that resembles the aggregation domain of prion proteins (prion-
related domain, or PRD) (21). The N-terminus of TIA-1/TIAR presumably binds to mRNA 
through its RNA recognition domains and sequesters the mRNAs and associated translation 
initiation factors and small ribosomal subunits into SGs by auto-aggregation of the prion-like 
C-terminal PRD of TIA-1/TIAR [reviewed in (3)]. Additional proteins, including Ras-GAP 
SH3 domain binding protein (G3BP) (51), tristetraprolin (TTP), Fragile X mental 
retardation-related protein (FMRP), as well as many others, have been implicated in SG 
formation [reviewed in (1)].  
Many viruses alter the normal course of SG induction during their replication cycle. 
For poliovirus, viral infection induces transient SG formation at an early phase of infection 
(2-6 h p.i.), and later disrupts SGs by cleaving SG component G3BP with poliovirus 3C 
proteinase (54). Semliki Forest virus (SFV) infection results in the shutoff of host protein 
synthesis largely due to activation of the cellular stress response via phosphorylation of 
eIF2  SFV infection also induces transient SG formation during the early phase of infection 
(2-5 h p.i.). Later, SGs are dispersed by an unknown mechanism (34). West Nile Virus 
disrupts SG formation by utilizing SG-effecter proteins TIA-1 and TIAR during RNA 
replication within viral replication complexes (17).  A previous study reported that MRV 
infection induces SGs in a strain-specific manner at late times post infection (19.5 h p.i) that 
correlates with the extent of host translation shutoff and eIF2 phosphorylation (47). 
Whether SGs are hurdles that must be overcome during viral translation has not yet been 
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fully determined. 
In this study we found cells infected with MRV transiently form SGs at an early 
phase of infection (2-6h.p.i.), which dissociate as infection progresses. 
eIF2 phosphorylation was found to be necessary for MRV induction of SGs, however, a 
single eIF2  kinase necessary for this phosphorylation was not identified. Utilizing known 
pharmaceutical inhibitors of virus disassembly and translation, as well as UV-inactivated 
virus, we identified the steps in the viral life cycle that are necessary or dispensable for SG 
induction. Finally, we show that MRV core particles are recruited to SGs in a manner that 
depends on synthesis of viral mRNA. 
Materials and methods  
Cells and reagents. CV-1 (African Green Monkey kidney fibroblast), HeLa (human cervical 
cancer cell), MEF (mouse embryonic fibroblast), PKR-/-, PERK-/-, GCN-/-, HRI-/-, 
MEFS51S/S51S and MEFS51A/S51A cells were maintained in DMEM (Dulbecco's 
modified essential medium, Invitrogen) containing 10% fetal calf serum (Atlanta 
Biologicals) and penicillin/streptomycin (100 IU/mL) (Mediatech). DU-145 cells were 
maintained in EMEM (Eagle’s modified essential media, Invitrogen) containing 10% fetal 
calf serum (Atlanta Biologicals), and penicillin/streptomycin (100 IU/mL). Spinner adapted 
L929 cells were maintained in c-MEM (Joklik's minimal essential medium, Sigma-Aldrich) 
containing 2% fetal calf serum, 2% fetal bovine serum (HyClone Laboratories), 2 mM L-
Glutamine (Mediatech) and penicillin/streptomycin (100 IU/mL) (Mediatech). Primary 
antibodies used in immunofluorescence and immunoblotting assays are as follows: goat 
polyclonal -TIA-1 antibodies (sc-1751), goat polyclonal -TIAR antibodies (sc-1749) 
(Santa Cruz Biotechnology, Inc.), rabbit polyclonal - -721A), rabbit 
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polyclonal -eIF3 antibodies (A300-376A) (Bethyl Laboratories), rabbit polyclonal -eIF4G 
antibodies (#2498), rabbit polyclonal -eIF4E antibodies (#9742), and rabbit polyclonal -
phospho-eIF2 Ser51) antibodies (#9721) (Cell Signaling Technologies). Mouse 
monoclonal antibody (7F4) against MRV structural protein , rabbit polyclonal - NS 
antiserum, and rabbit polyclonal -MRV core antiserum have been previously described (9, 
53). Rabbit antiserum against DCP1a has been described (26). Secondary antibodies used in 
immunofluorescence and immunoblotting experiments are as follows: Alexa 488- or Alexa 
594-conjugated donkey -mouse IgG antibodies, Alexa 488-conjugated donkey -goat IgG 
antibodies, Alexa 350- or Alexa 594-conjugated donkey -rabbit IgG antibodies 
(Invitrogen), and HRP-conjugated goat -rabbit IgG antibody (Invitrogen). Sodium Arsenite 
(SA) (Sigma-Aldrich) was used at a final concentration of 0.5 mM. E-64 (Roche) was used at 
a final concentration of 2 mM. Ammonium chloride (NH4Cl) was used at a final 
concentration of 2 mM. Puromycin (Invivogen) was used at final concentration of 0.1 
mg/mL. 
Virions and Intermediate Subvirion Particles (ISVPs). MRV stocks (T1L, T2J, T3D
C
) 
were obtained from Dr. Max Nibert (Harvard Medical School, Boston, MA). The superscript 
C in T3D
C
 is used to differentiate the T3D strain used in this study from another T3D strain 
(T3D
N
) that has previously been shown to differ in M1 gene sequence, factory morphology, 
and 2 ubiquitination phenotype (37). Purified virions were prepared as described (12) and 
stored in virion buffer (150 mM NaCl, 10 mM Tris pH 7.4, 10 mM MgCl2) at 4 °C. ISVPs 
were prepared as previously described (12, 41). Titers of purified virus were determined by 
standard MRV plaque assay in L929 cells (19). UV light-inactivated virions were prepared as 
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follows: MRV virions were diluted in virion buffer to a final titer (5.0  10
9
 pfu/ml), 0.9 
mL/well, in 6-well cell culture plates. The viral solution was exposed to UV light with the 
intensity of 1.0 Joules/cm
2
. The resulting virions were shown to retain viral entry by 
immunofluorescence assay, and additionally confirmed to be completely deficient in virus 
replication by plaque assay. 
Infection. 1.0  10
5
 or 2.0 10
5
 cells were seeded onto 12-well cell culture plates or 35 mm 
cell culture dishes the day before infection. Cells were infected with MRV virions, ISVPs or 
UV-inactivated virions at 10, 100 or 1000 pfu/cell as indicated in each experiment. Viral 
particles were diluted in phosphate buffered saline (PBS) [137 mM NaCl, 3 mM KCl, 8 mM 
Na2HPO4 (pH 7.5)] containing 2 mM MgCl2, and adsorbed to cells for 1 h, at which point, 
cells were overlayed with DMEM and incubated at 37°C until harvested. 
Immunofluorescence (IF) assay. Cells were seeded on six-well (9.6-cm
2
) dishes containing 
18-mm-diameter coverslips at a density of 2  10
5
 cells/well, then incubated overnight at 
37°C. At indicated times p.i., cells were fixed at room temperature for 10 min with 2% 
paraformaldehyde in PBS and then washed three times with PBS. Fixed cells were 
permeabilized by incubation with 0.2% Triton X-100 in PBS for 5 min and then washed three 
times with PBS. Samples were blocked for 10 min with 2% bovine serum albumin (BSA) in 
PBS. Primary and secondary antibodies were diluted in 2% BSA in PBS. After blocking, 
cells were incubated for 1 hour with primary antibody, washed three times with PBS, and 
then incubated for an additional hour with secondary antibody. Immunostained cells were 
washed a final three times with PBS, and mounted on slides with ProLong
®
 reagent with or 
without DAPI (4´,6-diamidino-2-phenylindole dihydrochloride) (Invitrogen). Immunostained 
samples were examined with a Zeiss Axiovert 200 inverted microscope equipped with 
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fluorescence optics. Confocal images were taken on a Leica SP5 X confocal microscope. For 
each field selected, a total of 35 0.1 m serial sections were taken horizontally. Images were 
prepared using Photoshop and Illustrator software (Adobe Systems).  
Immunoblotting assay. 2.0  10
5
 cells were seeded on 35 mm dishes the day before 
infection and then infected with viable and UV light-inactivated MRV virions as indicated.  
Infected cells were harvested at different times p.i., and lysed with 100 l lysis buffer (200 
mM Tris pH 8.0, 137 mM NaCl, 10% Glycerol, 1% NP-40). Protein concentrations for each 
sample were measured by EZQ  protein quantitation reagent (Invitrogen), and equivalent 
amounts of protein from each sample were separated by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were transferred to nitrocellulose by electroblotting in 
transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol [pH 8.3]). Nitrocellulose 
containing transferred proteins was blocked for 15 min with 5% non-fat skim milk in Tris-
buffered saline (20 mM Tris, 137 mM NaCl [pH 7.6]) containing 0.1% Tween-20 (TBS-T) 
and then incubated overnight with primary antibodies in TBS-T containing 1% milk. Blots 
were washed three times for 15 min each with TBS-T, followed by a 4 h incubation with 
HRP-conjugated secondary antibodies in TBS-T containing 1% milk. Blots were washed a 
final three times and exposed to Western Lightning 
TM 
plus–ECL enhanced 
chemiluminescence substrate (Perkin Elmer). Images were collected using a ChemiDoc
TM
 
XRS camera (Bio-Rad), and protein bands were quantified using Quantity-One software 
(Bio-Rad).  At least two independent experiments were performed, and a representative 
experiment is shown. 
SG quantification. Infected cells were immunostained at 2 or 4 hours p.i. as indicated in 
each experiment. More than 10 fields were randomly chosen and counted, with at least 200 
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cells counted for each sample slide. MRV core positive cells were recorded as infected cells, 
and SG-containing cells were counted from within the infected cell samples. The percentage 
of SG-containing cells in infected and uninfected cells was calculated and Pearson’s Chi-
squared test (X
2
) was applied to examine if there was a significant difference in SG 
formation between infected cells and non-infected cells. At least two independent 
experiments were performed, and a representative experiment is shown. 
Results 
MRV infection induces cytoplasmic structures containing SG marker proteins at 
early times p.i.  A previous study found that infection with MRV strains c87 and c8, and 
T3D induces SGs to differing degrees in the DU-145 prostate cancer cell line at late times p.i. 
(19.5 h p.i.) (47). To further explore the ability of MRV to induce SGs, we infected HeLa, 
CV-1, MEF and DU-145 cells with purified virions from MRV strains T1L, T2J, and T3D
C
. 
Mock infected cells, and cells treated with the known SG inducer, sodium arsenite (SA), 
served as negative and positive controls (data not shown). SA induces SGs in 98% of treated 
cells through activation of the heme-regulated inhibitor kinase (HRI) and phosphorylation of 
eIF2 . Cells were infected with virus
 
at 100 pfu/cell or 1000 pfu/cell, then examined 
throughout infection for cytoplasmic granules containing SG marker proteins using 
immunofluorescence microscopy. At early times p.i. (2-6 h), we found an increased number 
of T2J- and T3D
C
-infected cells which contained cytoplasmic granules positive for SG-
marker proteins G3BP, TIA-1, or TIAR compared to mock infected cells (Fig 1, and data not 
shown). We quantified the number of SG-containing cells following T3D
C
 virion infection 
(1000 pfu/cell, 4 h p.i.). We found that 34.2% of infected HeLa cells, 21.0% of infected CV-
1 cells, 35.6% of infected MEF cells, and 34.0% of DU-145 cells contained putative SGs, 
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whereas no uninfected HeLa, CV-1, or DU-145 cells and only 0.4% of uninfected MEF cells 
contained putative SGs. Pearson’s Chi-squared test (X2) (p<0.005) showed that infection of 
these four cell types with MRV T3D
C
 virions at 1000 pfu/cell induces SG formation in a 
significantly increased number of cells compared to non-infected cells at early times p.i.  
Unlike T2J and T3D
C
 virion-infected cells, we did not observe putative SGs in T1L 
virion-infected cells, even when the pfu/cell was increased to 10,000 (data not shown). We 
hypothesized that this was due to delayed entry of T1L virions into these cells based on a 
large decrease in cells containing viral core particles at early times p.i. as measured by 
immunofluorescence assay using antibodies specific for MRV core particles (data not 
shown).  In order to clarify this, we repeated these experiments using T1L, T2J, and T3D
C
 
ISVPs, which are predicted to directly enter the cell through membrane penetration. Similar 
to our findings with T2J and T3D
C
 virions, all T1L, T2J, and T3D
C
 ISVPs induced 
cytoplasmic structures that stained with SG-marker proteins in HeLa, CV-1, and MEF cells 
at early times p.i. (Fig. 2A and data not shown). This suggests that the inability of T1L 
virions to induce SGs is based on a deficiency in virus entry in these cell types. Furthermore, 
MRV ISVPs induce SGs in a dose-dependent manner (Fig. 2B), with the number of SG-
positive cells increasing with viral particle number used to infect the cells. We found that at 
later times in virus infection (8-24 h p.i.), as viral protein translation increased and viral 
factories became the prominent structures within the cytoplasm, SGs were no longer present 
in any tested cell type infected with 1, 10, 100, or 1000 pfu/cell with T1L, T2J, or T3D
C
, 
unlike the previous report that MRV induces SGs at late times p.i.(Fig. 5B, Fig. 6, top right 
panel, and data not shown) (47).  
MRV-induced SGs are structurally similar to SGs induced by eIF2  
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phosphorylation. Because there are a growing number of cytoplasmic structures that form in 
cells in response to different stresses [reviewed in (3)], we further characterized SGs induced 
by MRV infection to determine if they contained components, such as translation initiation 
factors (eIF4G, eIF4E, and eIF3), that are characteristic of SGs induced by phosphorylation 
of eIF2 , and other types of protein synthesis inhibition (25). HeLa cells were infected with 
ISVPs (T1L, T2J and T3D
C
) or MRV virions (T2J, T3D
C
) with 1000 pfu/cell. At 2 h p.i. or 4 
h p.i., cells were fixed for three-color immunofluorescence using mouse antibody (7F4) 
against viral core protein 2 to visualize infected cells, goat antibodies against TIAR or TIA-
1 to visualize SGs, and rabbit antibodies against eIF4G, eIF4E, or eIF3 to visualize 
translation initiation factors. Mock cells, and sodium arsenite (SA)-treated cells were used as 
negative and positive controls for SG formation (data not shown).  SG effecter proteins TIAR 
(or TIA-1) colocalized in independent experiments with eIF3 (Fig. 3, rows 1 and 2), eIF4G 
(Fig. 3, row 3), and eIF4E (Fig. 3, row 4) in the granules that formed in MRV-infected cells. 
As a negative control for SGs, we examined the localization of DCP1a, a marker for 
processing bodies (PBs) (26), and found that this protein did not localize in the structures 
induced by MRV infection and was found instead in small separate structures that are likely 
PBs (Fig. 3, row 5). These results indicate MRV-induced SGs are structurally similar to those 
induced by inhibition of protein translation initiation and eIF2 phosphorylation.  
Viral uncoating is required for MRV induction of SGs. To unravel the steps in 
MRV infection that are necessary for induction of SGs, we examined the effects of 
previously described pharmaceutical inhibitors of viral uncoating (ammonium chloride and 
E-64) on the ability of MRV infection to induce SGs. It has previously been shown that these 
drugs are able to block viral uncoating by changing the pH of endosomes (ammonium 
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chloride) or blocking endosomal protease activity (E-64) (5, 49). HeLa cells were pretreated 
with 2 mM ammonium chloride or 2 mM E-64 for 4 h preceding infection. Following this 
incubation, cells were infected with T3D
C
  virions (1000 pfu/cell), and incubated for 1 h at 
room temperature, then re-treated with ammonium chloride or E-64 at the above 
concentrations. At 4 h p.i. and 8 h p.i., cells were fixed and stained with antibodies to detect 
viral cores and SGs. In contrast to untreated, infected cells that contain both core particle 
staining and SGs (Fig. 4, row 3), neither core particle staining or SGs were observed in the 
ammonium chloride- or E-64-treated, infected cells at 4 h p.i. (Fig. 4, rows 1 and 2). Control 
experiments indicate that ammonium chloride or E-64 do not induce SGs or prevent SG 
formation induced by SA (Fig. 4, rows 4 and 5). At 8 h p.i., MRV virions were still unable to 
uncoat and induce SGs (data not shown). These results suggest viral uncoating is required for 
SG induction. 
UV-inactivated MRV virions induce SGs. In order to examine whether gene 
expression is involved in SG induction, we examined the ability of UV-inactivated virions to 
induce SGs.  T3D
C
 virions were inactivated by UV light treatment as described in Materials 
and Methods. HeLa cells were infected with untreated T3D
C
 virions, or UV-treated T3D
C
 
virions and at 0, 2, 4, 6, 12, and 24 h p.i., cells were fixed and immunostained to detect viral 
core particles and SGs. We found that similar to untreated virions (Fig. 5A, row 1), UV-
inactivated virions were able to enter cells and to induce SGs (Fig. 5A, row 2). Additionally, 
we quantified the number of SGs that were induced by active versus inactive viruses over 
time (Fig. 5B). Interestingly, UV-inactivated virions induced higher percentages of SG-
containing cells throughout MRV infection in comparison to viable MRV infected cells (Fig. 
5B). In fact, by 12 h p.i., less than 5% of cells infected with active MRV contained SGs, 
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whereas, nearly 40% of cells infected with UV-inactivated virus still contained SGs at this 
time.  By 24 h p.i., no actively infected cells contained SGs, while 20% of cells infected with 
UV-inactivated MRV still contained SGs.   These results suggest that SG induction is mainly 
due to viral entry events.  Moreover, because cells containing SGs appear to rapidly decrease 
as viral mRNA is transcribed and translated in actively infected cells, but remain present in a 
large number of cells infected with virus that is unable to express protein, these results also 
suggest that viral gene expression may be involved with SG disruption as viral infection 
progresses.  The reason for the decline over time of SG-containing cells following infection 
with UV-inactivated virus remains to be determined. 
Translation is dispensable for SG induction, but required for SG disassembly in 
MRV infected cells.  To further examine the role of viral mRNA transcription and 
translation in MRV induction of SGs, we examined MRV-induction of SGs in the presence 
of a known pharmaceutical inhibitor of translation (puromycin). Puromycin is a general 
inhibitor of cellular and viral protein translation that inhibits translation elongation by 
forming methionyl-puromycin (31).  HeLa cells were treated with puromycin for 1 h 
preceding infection. Following this incubation, cells were infected with T3D
C
 virions at 1000 
pfu/cell, and incubated for 1 h at room temperature, at which point cells were re-treated with 
puromycin at the above concentration. At 10 h p.i., cells were fixed and stained with 
antibodies to detect viral cores and SGs. In untreated, infected cells, at 10 h p.i., rabbit -core 
antiserum stained viral factories, and only 2.2% of infected cells formed SGs (Fig. 6A, row 
1), confirming our previous observations that SGs dissipate as MRV infection proceeds. In 
puromycin-treated, infected cells, no viral factories were present as a result of puromycin 
translation inhibition, however, 88.3% of cells contained SGs (Fig. 6A, row 2) at this time. In 
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uninfected, puromycin-treated cells, only 2.5% of cells formed SGs (Fig.6A, row 3, left). 
Similar to previously reported data (50), puromycin treatment did not prevent SA-induction 
of SG, and 99.0% of SA-treated cells contained SGs (Fig. 6A, row 3, right). Immunoblots 
against MRV non-structural protein NS confirmed no MRV protein synthesis in the 
puromycin treated, infected cells at 10 h p.i., while untreated cells contained significant 
levels of NS synthesis (Fig. 6B). These results suggest that viral translation is not required 
for MRV-induction of SGs. They further suggest, similar to our results with UV-treated 
virions, that when viral protein synthesis is inhibited, the SGs that form in response to MRV 
infection are not disrupted. This again implicates a role for MRV protein expression in SG 
disruption as viral infection proceeds from early to late times.  
eIF2  phosphorylation correlates with, and is required, for MRV-induction of 
SGs. Many lines of evidence suggest that eIF2  phosphorylation is sufficient to induce SGs 
(29), however, a number of drugs and small molecules have been described that can induce 
SGs independently of eIF2  phosphorylation (38). These include the small molecule 
NSC119893, which inhibits the interaction between eIF2  and Met-tRNA (38), and the 
drugs pateamine (15) and 15D-PGJ2 (28), which bind and inhibit translation initiation factor 
eIF4A. To determine if MRV induction of SGs correlates with phosphorylation of eIF2 , we 
examined the relative levels of phosphorylated eIF2  compared to total cellular eIF2  during 
MRV infection at times in which SGs were present. HeLa cells were infected with untreated 
or UV-treated T3D
C
 virions, and at 0, 2, 4, and 6 h p.i. samples were collected. Proteins were 
separated on SDS-PAGE, transferred to nitrocellulose, and probed with antibodies against 
MRV non-structural protein NS, total eIF2 , and phosphorylated eIF2  (Fig. 7A). These 
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experiments show that the level of phosphorylated eIF2  increases in both active virus-
infected cells (Fig. 7A, left panel) and UV-inactivated virus-infected cells (Fig. 7A, right 
panel) at times when SGs are routinely found in MRV-infected cells. This suggests MRV-
induced SG formation may occur as a result of eIF2  phosphorylation. 
In order to examine whether phosphorylation of eIF2  is required for MRV induction 
of SGs, we utilized a cell line, MEF
S51A/S51A
, in which the eIF2  gene is genetically altered 
such that the serine residue at amino acid 51 is changed to an alanine. This results in loss of 
the phosphorylation event that is necessary to inhibit ternary complex formation (46). 
MEF
S51A/S51A
 are unable to form SGs following sodium arsenite treatment, which activates 
eIF2  phosphorylation through the HRI kinase, but are able to form SGs following treatment 
with NSC11893 (38), pateamine A (15), or 15D-pGJ2 (28). Wildtype MEF
S51S/S51S 
and 
mutant MEF
S51A/S51A 
cells were infected with ISVPs (T1L, T2J, or T3D
C
) or virions (T2J, 
T3D
C
) at 1000 pfu/cell. At 2 h p.i. or 4 h p.i., cells were fixed and stained for 
immunofluorescence with antiserum against MRV cores to visualize infected cells, and 
antibodies against TIAR to visualize SGs. In these experiments, although we counted varying 
numbers of SG-containing cells in infected wildtype MEF
S51S/S51S 
cells (ranging from 13%-
54% depending on virus strain, and particle type used), we did not detect any infected cells 
containing SGs in the mutant MEF
S51A/S51A 
cells (Fig. 7B and data not shown). These 
findings suggest that SG induction by MRV occurs through a pathway that requires eIF2  
phosphorylation.   
At least two eIF2 kinases are involved in MRV induction of SGs. Because our 
data suggested that eIF2  phosphorylation is required for SG formation at early times in 
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infection, we were interested in further identifying the cellular pathway involved in MRV 
induction of SGs.  Four kinases have been identified that phosphorylate eIF2  in response to 
different cellular stresses. These include PKR, which is activated by viral infection, PERK, 
which is activated by protein misfolding in the endoplamic reticulum (ER), GCN, which is 
activated by nutrient deprivation, and HRI, which is activated by oxidative stress [reviewed 
in (3)]. We utilized a knockout cell line for each of the four eIF2  kinases (PKR-/-, PERK-/-, 
HRI-/-, GCN-/-) to determine if knockout of any individual stress kinase results in loss of SG 
formation following MRV infection. Each cell line was infected with T3D
C
 at 1000 pfu/cell, 
and at 4 h p.i., cells were fixed and immunostained to visualize viral cores and SGs. We 
found that each individual knockout cell line was able to form SGs in response to MRV 
infection with 36.5 % GCN-/- cells, 40.1 % PERK-/- cells, 19.1 % PKR-/- cells, and 13.2 % 
HRI-/- cells containing SGs (Fig. 8, left and middle columns). Only rare cells contained SGs 
in these cell lines when they were mock-infected (Fig. 8, right column). These results 
indicate that at least two eIF2  kinases can be activated to phosphorylate eIF2  by MRV 
infection at early times p.i., and suggest that the signaling pathway leading to SG induction 
by MRV infection is more complex than activation of a single eIF2a kinase. 
Viral core particles are recruited to SGs in a transcription-dependent manner. In 
our study, we found that in MRV-infected, SG-containing cells, a portion of viral core 
particles localized to SGs at early times p.i. (Fig. 1, 2, 3, 4, 5, 6, 7, 8). This colocalization 
was variable depending on cell type and experiment, however in each experiment, core 
particles were visualized in SGs.  In order to confirm these findings, we examined MRV core 
and SG localization using confocal microscopy. HeLa cells were infected with T1L ISVPs, 
and at 2 h p.i., cells were fixed and stained with antibodies against MRV cores and TIAR to 
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visualize core particle localization relative to SGs. Confocal images confirmed that many, but 
not all, viral core particles are intensely localized in SGs induced by MRV (Fig. 9A). To 
determine whether gene expression is necessary for the localization of viral cores to SGs, we 
examined the localization of viral core particles in UV-inactivated infected cells, and 
puromycin-treated, infected cells. UV irradiation is expected to prevent viral transcription 
(and in our studies, we found no evidence of protein translation or replication following UV-
treatment of particles; see Fig. 7A, and data not shown). Puromycin is not expected to 
prevent viral transcription but is expected to prevent viral translation (and in our studies we 
did not detect viral protein translation following puromycin-treatment, see Fig. 6B) (31). In 
these experiments, we found that in the cells infected with UV-inactivated viruses, no viral 
core particles colocalized in SGs (Fig. 9B).  However, in the puromycin-treated, infected 
cells, although not all viral core particles localized to SGs,, by 10 h p.i, almost all cells 
formed SGs which contained viral core particles (Fig. 9C). These findings suggest that the 
localization of viral core particles to SGs may be mediated by newly synthesized viral 
mRNA. The absence of complete colocalization of core particles with SGs is likely a result 
of two issues. First, virion preparations always contain a portion of viral particles defective in 
viral transcription, and second, some cores are likely not actively synthesizing viral mRNA at 
the moment when cells were fixed for immunostaining. While viral core particles may be 
targeted to SGs via viral mRNA, it has yet to be determined whether viral mRNA, like 
cellular mRNA, is translationally silent when cores are sequestered in SGs.  
Discussion 
Viral entry is required for MRV-induction of SGs. SG formation is a defensive 
mechanism used by host cells in response to many types of external or internal stresses (2). 
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The size and number of SGs within cells are dependent on the intensity of different stresses. 
For example, SA induces SGs in a dose-dependent manner, with a lower dose of SA inducing 
fewer and smaller stress granules, and vice versa (2). In these studies, we also found that the 
number of cells containing MRV-induced SGs is dependent on the levels of core particle 
entry into the cytoplasm. ISVPs from all prototype viral strains were able to induce SG 
formation in a dose-dependent manner, with increasing pfu/cell resulting in increasing 
numbers of SG-containing cells. In fact, using ISVPs, a significant amount of SGs could be 
induced at 10 pfu/cell (Fig. 2). It is important to note that our experiments quantifying 
numbers of SG-containing, infected cells are complicated by the fact that viral infection and 
SG-formation are both dynamic processes. Because cells and viral infections are not 
synchronized in these experiments, fixation for immunofluorescence represents only a 
snapshot of a population of cells at one moment in time. It is likely that infected cells will be 
at different stages of these dynamic processes at this moment, and that the percentage of cells 
in which MRV induces SGs is much higher than what is indicated in these experiments.  In 
fact, we found that when MRV gene expression was inhibited by UV inactivation (Fig. 5) or 
by puromycin treatment (Fig. 6), much higher percentages of SG-containing infected cells 
were observed in these assays. MRV produces 200-3000 plaque forming units in each 
infected cell (40). All of these viruses are likely released simultaneously into the surrounding 
cellular matrix by cell lysis, making it likely that the conditions used in our experiments are 
biologically relevent.  
SG induction by MRV requires viral uncoating but not viral gene transcription 
and translation. Previous studies showed that MRV infection induces phosphorylation of 
eIF2 at late times p.i., likely through activation of PKR kinase during viral replication, 
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resulting in SG formation (47). However, in our study, we tested several cell lines (HeLa, 
L929, MEF, CV-1, Cos-7, DU-145) and found that no SGs formed in cells containing the 
large, perinuclear VFs that form in infected cells at late times in infection (12-24 h p.i.). We 
consistently visualized a small percentage of SG-containing, infected cells expressing very 
low levels of viral protein when we examined SGs at late times p.i. (Fig. 5B, Fig. 6A and Qin 
and Miller, unpublished data). These findings suggest that as MRV infection continues, 
MRV-induced SGs are dispersed. We cannot fully explain the difference in our data to the 
published report indicating that MRV-infected cells contain SGs at late times p.i. We have 
tested more than ten cell lines (in this study, and data not shown), and the presence of SGs at 
early, but not late, times in MRV infection does not appear to be cell-type specific. 
Moreover, while we have demonstrated that the induction of SGs following MRV infection is 
dependent on pfu/cell, the absence of SGs in cells at late times in infection is not dependent 
on pfu/cell, as cells expressing high levels of MRV protein following infection with 1, 10, 
100, or 1000 pfu/cell also do not contain SGs at later times p.i. (Fig. 5B, Fig. 6A, and data 
not shown). It is also interesting that a recent report has shown that the highly related 
rotavirus also does not contain SGs at late times in infection, even though eIF2  is 
phosphorylated at these times (39).    
In order to understand the mechanism of SG induction by MRV, we chose some well 
defined pharmaceutical inhibitors to block specific steps of viral infection to identify which 
step is required for SG induction. We found viral uncoating is required for SG formation 
based on the fact that treatment of cells with ammonium chloride and E-64, which inhibit the 
cleavage and subsequent conformation changes of outer capsid proteins ( 3 and 1) in the 
endosome, prevents the formation of SGs following MRV infection (Fig. 4).  We also found 
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that viral transcription and translation are not required for SG formation based on the fact 
that UV-inactivated MRV virions and ISVPs still retain their ability to induce SGs (Fig 5A), 
and cells treated with puromycin are still able to form SGs (Fig 6A) even though viral 
translation is completely inhibited. These findings suggest MRV-induction of SGs is mainly 
dependent on viral entry and precedes viral protein synthesis and replication.  
Phosphorylation of eIF2 is a key factor for SG formation in response to MRV 
infection during viral entry. SG formation is a complicated process, and the mechanism 
involved in the formation and dispersal of these structures is poorly understood. Formation of 
SGs can be induced by phosphorylation of eIF2 , inhibiting the formation of ternary 
complex (eIF2-GTP-tRNAi
Met
), or interfering with translation initiation factors [eIF4A (15), 
eIF4B, eIF4H, or PABP (38)]. Phosphorylation of eIF2  appears to play an important role in 
SG-induction by some, but not all viruses (18, 34). This is not surprising given the fact that 
many viruses activate PKR, including alphavirus (52), reovirus (47), rotavirus (39), and 
influenza viruses (22). Herpes simplex virus 1 activates PERK as well as PKR (13). 
Activated PKR or PERK phosphorylate eIF2  on Ser 51, which leads to the failure of ternary 
complex formation (eIF2-GTP-tRNAi
Met
), leading to SG formation (25). Our data shows that 
phosphorylaton of eIF2  is required for SG formation following MRV infection (Fig. 7). 
However, PKR does not appear to be the only kinase that phosphorylates eIF2  during MRV 
infection. We found MRV infection induces SGs in a PKR-/- cell line as well as other eIF2  
kinase knockout cell lines (GCN-/-, PERK-/-, and HRI-/-) (Fig. 8). We speculate, based on 
this data, that MRV infection can induce eIF2  phosphorylation through a number of 
pathways. It has previously been shown that MRV infection activates the unfolded protein 
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response, which involves the PERK kinase (47), raising the possibility that both PKR and 
PERK kinases may play a role in MRV induction of SGs. 
The recruitment of viral cores in SGs may be a consequence of pathogen-host co-
evolution. During MRV-induced SG formation, we observed many viral core particles 
localized in SGs (Fig. 9A). Our data suggests viral mRNA transcription is necessary for core 
localization to SGs. How newly synthesized viral mRNA might mediate core particle 
localization to SGs is unknown. Following the release of core particles into the cytoplasm, 
they do not further disassemble (56). Viral core particles directly transcribe viral mRNA 
from within the core, and newly synthesized viral mRNA is released from 2-formed turrets 
as mRNA synthesis proceeds (56). We propose the process of SG formation is triggered as a 
result of phosphorylation of eIF2  during viral entry. It is possible that during SG assembly, 
some major component(s) of SGs such as RNA binding proteins TIAR, TIA-1 (27), G3BP 
(51), FMRP (16), or Stau 1 (50), play a role in sequestering viral mRNA and its associated 
core particles into SGs. SGs sequester and translationally silence mRNA. Some stress-
induced transcripts, such as ATF4, GCN4, and Hsp70 are selectively translated when SGs are 
present in cells (24), although the molecular features that distinguish between constitutive 
and stress-induced transcripts are not well understood. For West Nile virus, TIAR and TIA-1 
interact with the 3’ stem-loop of the complementary minus-strand RNA and facilitate virus 
replication. This finding suggests that viruses can either escape SG arrest or take advantage 
of SGs. Whether MRV translation is inhibited by SGs is undetermined, although, in every 
case in this study, MRV infection continued following SG-formation. Our data suggests that 
SGs are diminished as viral proteins accumulate (Fig. 5B, Fig. 6A, panel 1, and data not 
shown), suggesting that SGs are disassembled as infection proceeds. It is unlikely that the 
64 
 
 
 
dissolution of SGs seen in MRV infected cells relieves the host cell translation shutoff seen 
following infection with some strains of MRV, because in our experiments SGs were absent 
at late times p.i. in cells infected with both viral strains that induce host translational shutoff 
(T2J), and those that do not induce host cell translational shutoff (T3D
C
).  However, SG 
disruption may be necessary for the synthesis of viral protein in the translational shutoff 
environment. MRV induction and disruption of SGs, and subsequent escape from the 
translation inhibition that is a consequence of this induction could be the consequence of co-
evolution between MRV and the host cell. 
SGs and MRV factories.  SG formation depends on the microtubule network (23). 
The deacetylase HDAC6 was proposed to coordinate the formation of SGs by mediating the 
motor-protein-driven movement of SG components along microtubules (30). During MRV 
infection, the viral core protein 2, and the VF structural matrix protein, NS, are associated 
with the microtubule network.  While the association of 2 with microtubules plays a role in 
VF morphology, the association of NS with microtubules appears to be important for the 
development of MRV factories from small structures scattered throughout the cytoplasm, to 
larger perinuclear structures (10, 43). MRV core particles are embedded in microtubule-
associated VFs (4, 8) and associate with NS, both in vitro and in vivo (9, 10). The fact that 
NS binds to viral cores, and uses the microtubule network to facilitate VF formation, 
coupled with our findings that viral core particles colocalize with microtubule associated-
SGs at very early times p.i. suggests there may be a link between SGs and VF formation. The 
possibility that MRV VFs may nucleate around core-containing MRV-induced SGs through 
interactions between NS, viral cores, and the microtubule network will be interesting to 
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examine in future studies.   
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Figure 1.  Infection with MRV induces SG formation at early times p.i. HeLa (first row), 
MEF (second row), CV-1 (third row), and DU-145 (fourth row) cells were infected with 
MRV T3D
C
 virions (1000 pfu/cell). At 4 h p.i., cells were fixed and immunostained with 
rabbit -MRV core polyclonal antiserum (left column) and mouse monoclonal antibody 
against G3BP (first row, right column), goat -TIA-1 (second row, right column), or goat -
TIAR (third and fourth rows, right column) polyclonal antibodies, followed by Alexa 594-
conjugated donkey -rabbit IgG and Alexa 488-conjugated donkey -mouse IgG or donkey 
-goat IgG. More than 200 infected cells were counted from each slide and percentage of 
infected cells containing SG-like granules at the time of fixation is indicated.  Scale bars=10 
m.  
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Figure 2. Infection with MRV ISVPs induces SG formation in a dose dependent manner 
(A) HeLa cells were infected with T1L ISVPs (top row), T2J ISVPs (middle row) or T3D
C
 
ISVPs (bottom row) (1000 pfu/cell). At 2 h p.i., cells were fixed and immunostained with 
rabbit -MRV core antiserum (left column) and goat polyclonal -TIAR antibodies (right 
column) followed by Alexa 594-conjugated donkey -rabbit IgG and Alexa 488-conjugated 
donkey -goat IgG. Scale bars=10 m. (B) Cells were infected with MRV ISVPs (T1L, T2J, 
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T3D
C
) at 10, 100, or 1000 pfu/cell, and fixed and immunostained as in (A).  More than 200 
infected cells were counted in each treatment to calculate the percentage of infected cells 
containing SG-like granules at the time of fixation.  
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Figure 3. MRV-induced SGs contain translation initiation factors eIF3, eIF4G, eIF4E 
but not P body component DCP1a. HeLa cells were infected with T1L ISVPs (1000 
pfu/cell) for 2 h, then fixed and immunostained with mouse - 2 monoclonal antibody (7F4) 
to visualize MRV cores (left column), goat -TIA-1 or goat -TIAR antibodies (second 
column), and rabbit -eIF3, eIF4G, eIF4E antibodies, or DCP1a antisera (third column) 
followed by Alexa 594-conjugated donkey -mouse IgG, Alexa 488-conjugated donkey -
goat IgG, and Alexa 350-conjugated donkey -rabbit IgG. Merged images are shown in right 
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column. Scale bars=10 m.  
 
 
Figure 4. Ammonium chloride and E-64 prevent MRV induction of SGs. HeLa cells 
were pretreated with 2 mM ammonium chloride (NH4Cl) (row 1), 2 mM E-64  (row 2), or 
left untreated (row 3) for 4 hours, then infected with MRV T3D
C
 virions (1000 pfu/cell). At 4 
h p.i., cells were fixed and immunostained with rabbit -MRV core polyclonal antisera (rows 
1, 2, 3; left columns) and goat -TIAR polyclonal antibodies (rows 1, 2, 3; right column), 
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followed by Alexa 594-conjugated donkey -rabbit IgG and Alexa 488-conjugated donkey 
-goat IgG.  Uninfected HeLa cells were treated with 2 mM ammonium chloride (row 4), or 
2 mM E-64 (row 5), and incubated (rows 4,5; left column), or additionally treated for 1 h 
with 0.5 mM SA (rows 4, 5; right column), then fixed and stained with goat -TIAR 
polyclonal antibodies followed by Alexa 594-conjugated donkey -rabbit IgG. Scale bars=10 
m.   
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Figure 5. UV-inactivated MRV virions induce SGs.  (A) HeLa cells were infected with 
untreated (top row) or UV-inactivated (bottom row) T3D
C
 virions (1000 pfu/cell). Cells were 
fixed at 4 h p.i., and immunostained with rabbit -MRV core polyclonal antiserum (left 
column) and goat -TIAR antibodies (right column), followed by Alexa 594-conjugated 
donkey -rabbit IgG and Alexa 488-conjugated donkey -goat IgG. (B) HeLa cells were 
infected, fixed and immunostained as in (A) at 2, 4, 6, 12, and 24 h p.i.  The percentage of 
infected cells containing SGs was calculated at each time point as described in Materials and 
Methods.  
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Fig 6. Puromycin inhibits viral translation, but does not prevent MRV induction of 
SGs.  (A) HeLa cells were untreated (row 1) or pretreated with 0.1 mg/ml puromycin (row 2) 
for 1 h, then infected with MRV T3D
C
 virions (1000 pfu/cell) for 1 h. New medium 
containing 0.1 mg/ml puromycin was added to cells following infection (row 2). At 10 h p.i., 
cells were fixed and immunostained with rabbit -MRV core polyclonal antisera (rows 1, 2; 
left column) and goat -TIAR polyclonal antibodies (rows 1, 2: right column), followed by 
Alexa 594-conjugated donkey -rabbit IgG and Alexa 488-conjugated donkey -goat IgG. 
Uninfected HeLa cells were treated with 0.1 mg/ml puromycin  (row 3; left and right 
column), and incubated (left column) or treated with 0.5 mM SA for 1 h (right column) after 
9 h puromycin treatment, then fixed and stained with goat -TIAR polyclonal antibodies 
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followed by Alexa 488-conjugated donkey -goat IgG. Following immunostaining, the 
percentage of infected cells containing SGs (rows 1, 2) or total cells containing SGs (row 3) 
was quantified as described in Materials and Methods. Percentages of SG-containing cells 
are indicated.  Scale bars=10 m. (B) HeLa cells were infected  with MRV T3D
C
 virions 
(1000 pfu/cell) with or without 0.1 mg/ml puromycin (Pm) as indicated, and at 4 and 10 h 
p.i., cells were lysed, and proteins were separated by SDS-PAGE followed by 
immunoblotting using - NS polyclonal antiserum, or - -actin polyclonal antibodies. 
Proteins were detected using HRP-conjugated goat -rabbit IgG, followed by 
chemiluminescence imaging. 
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Fig 7. eIF2  phosphorylation correlates with and is required for MRV induction of 
SGs. (A) HeLa cells were infected with untreated or UV-inactivated T3D
C
 virions (1000 
pfu/cell), and cells were harvested at 0, 2, 4, and 6 h p.i. Following cell lysis, proteins were 
separated by SDS-PAGE and immunoblotted using rabbit - NS polyclonal antiserum, 
rabbit -eIF2  polyclonal antibodies, and rabbit -phospho-eIF2  polyclonal antibodies. 
Proteins were detected and quantified using HRP-conjugated goat -rabbit antibodies, 
followed by chemiluminescence imaging. Levels of phosphorylated eIF2  relative to total 
eIF2  at each time point were calculated, normalized to the level seen at t=0 and are 
indicated below each time point. (B) MEF
S51S/S51S
 (S/S) (row 1) and MEF
S51A/S51A
 (A/A) (row 
2) cells were infected with MRV T3D
C 
virions (1000 pfu/cell). At 4 h p.i., cells were fixed 
and immunostained with rabbit -MRV core antiserum (left column) and goat -TIAR 
polyclonal antibodies (right column), followed by Alexa 594-conjugated donkey -rabbit 
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IgG and Alexa 488-conjugated donkey -goat IgG. Scale bars=10 m. 
 
 
Fig 8. MRV induces SG formation in eIF2  kinase knockout cell lines. GCN-/- (row 1), 
PERK-/- (row 2), PKR-/- (row 3), or HRI-/- (row 4) cells were infected with T3D
C
 virions 
(1000 pfu/cell) (left and middle columns), or mock infected (right column). At 4 h p.i., cells 
were fixed and immunostained with rabbit -MRV core antiseum (left column) and goat -
TIAR polyclonal antibodies (middle, and right columns), followed by Alexa 594-conjugated 
donkey -rabbit IgG and Alexa 488-conjugated donkey -goat IgG. More than 200 infected 
cells were counted from each slide and percentage of infected cells containing SG-like 
granules at the time of fixation is indicated. Scale bars=10 m. 
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Fig 9. MRV core particles colocalize with SGs in a manner dependent on viral gene 
expression. (A) HeLa cells were infected with MRV T1L ISVPs (1000 pfu/cell). At 2 h p.i., 
cells were fixed and stained with rabbit -MRV core antiserum (left) and goat -TIAR 
antibodies (middle), followed by Alexa 594-conjugated donkey -rabbit IgG and Alexa 488-
conjugated donkey -goat IgG. Merged image is shown (right). Confocal images were taken 
at 0.1 m slice intervals using a Leica SP5 X confocal microscope. The boxed regions in 
each image were amplified and are shown in insets in the merged image. (B) HeLa cells were 
infected with UV-inactivated T3D
C
 virions (1000 pfu/cell). At 4 h p.i., cells were fixed and 
stained with rabbit -MRV core antiserum (left), and goat -TIAR antibodies (middle). 
Merged image is shown (right).  The boxed region in the merged image was amplified and is 
shown in inset. (C) HeLa cells were pretreated with 0.1 mg/ml puromycin for 1 h, incubated 
with T3D
C
 virions  (1000 pfu/cell) for 1 h, then retreated with puromycin for an additional 10 
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h, at which point, cells were fixed and stained with rabbit -MRV core antiserum (left), and 
goat -TIAR polyclonal antibodies (middle). Merged image is shown (right). The boxed 
region in the merged image was amplified and is shown in inset.  
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Abstract 
 
In response to mammalian orthoreovirus (MRV) infection, cells initiate a stress response, 
which includes eIF2α phosphorylation and protein synthesis inhibition. We have previously 
shown that early in infection MRV activation of eIF2α phosphorylation results in the 
formation of cellular stress granules (SGs).  In this work we show that as infection proceeds, 
MRV disrupts SGs despite sustained levels of phosphorylated eIF2 , and further, interferes 
with the induction of SGs by other stress inducers. MRV interference with SG formation 
occurs downstream of eIF2α phosphorylation suggesting the virus uncouples the cellular 
stress signaling machinery from SG formation. We additionally examined mRNA translation 
in the presence of SGs induced by eIF2α phosphorylation dependent and independent 
mechanisms. We found that irrespective of eIF2α phosphorylation status, the presence of 
SGs in cells correlated with inhibition of viral and cellular translation.  In contrast, MRV 
disruption of SGs correlated with release of viral mRNAs from translational inhibition, even 
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in the presence of phosphorylated eIF2α.  Viral mRNAs were also translated in the presence 
of phosphorylated eIF2α in PKR-/- cells.  These results suggest that MRV escape from host 
cell translational shutoff correlates with virus-induced SG disruption, and occurs in the 
presence of phosphorylated eIF2α in a PKR independent manner. 
Introduction  
The non-fusogenic mammalian orthoreoviruses (MRV) are a member of a large 
family of animal and plant viruses (Reoviridae), which includes many members that are of 
considerable importance in human, animal and plant disease (24).  Members of this virus 
family share a number of strategies for viral invasion and growth within host cells.  
Following infection with many of the viruses from this family, including MRV, the host cell 
initiates a stress response that culminates in shutoff of protein translation (5, 26, 37). 
Remarkably, viral RNAs are able to escape this inhibition and continue to be translated in the 
shutoff environment. (34, 36, 47).  In the case of MRV, the innate immune response has been 
implicated in host translational shutoff via activation of the dsRNA kinase, PKR (6, 15, 31, 
34, 39). PKR is activated by binding dsRNA, at which point it homodimerizes and undergoes 
autophosphorylation (46). Activated PKR phosphorylates serine 51 on the alpha subunit of 
the cellular translation initiation factor eIF2 (17).  In the absence of cellular stress, eIF2  
binds to GTP and initiatior methionyl-tRNA (met-tRNAi), to form a ternary complex which 
subsequently binds to the 40S ribosomal complex to form the 43S pre-initiation complex. As 
translational initiation proceeds, eIF2-bound GTP is hydrolyzed to release initiation factors 
from the ribosome that then continues with translation elongation. Following release, the 
GDP bound to eIF2 must be exchanged for GTP in a reaction that is catalyzed by the guanine 
nucleotide exchange factor, eIF2B. Upon this exchange, eIF2-GTP can again bind met-
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tRNAi to initiate a new round of translation. When eIF2  is phosphorylated, it changes from 
a substrate of eIF2B to a competitive inhibitor that binds eIF2B with high affinity, inhibiting 
the exchange of GDP for GTP. This binding results in global inhibition of protein synthesis 
[reviewed in (25, 27)]. There is an excess of eIF2  relative to eIF2B in cells, therefore, very 
little eIF2  phosphorylation can result in inhibition of protein synthesis (13). mRNAs whose 
expression is required for response to cellular stress, as well as RNAs of other viruses that 
induce host translational shutoff, escape this inhibition in a variety of ways (44).   
       It has previously been shown that some strains of MRV prevent host cell translational 
shutoff (4). The MRV structural protein, 3, was found to play a key role in MRV 
interference with the host cell translational inhibition response in these strains (6, 15, 33, 35). 
MRV reassortants containing the gene for encoding 3 proteins from non-host-shutoff strains 
were shown to prevent host shutoff in the otherwise genetic background of host-shutoff 
strains (36). 3 is a sequence-independent dsRNA binding protein which can functionally 
replace both vaccinia virus VAI RNA and adenovirus E3L protein, both known to be PKR 
inhibitors (6, 15). Based on this, it was proposed that 3 from MRV strains that prevent host 
shutoff bind dsRNA and interferes with PKR activation following MRV infection, thereby 
preventing eIF2  phosphorylation and subsequent translational inhibition. Previous studies 
also suggest that differences in host translational shutoff induced by MRV strains may result 
from differences in the intracellular localization of 3 in infected cells (34). In these studies, 
MRV strains that prevent host translational shutoff were found to have 3 diffusely 
distributed throughout the cytoplasm, and MRV strains that do not prevent host cell 
translation shut-off were shown to contain 3 localized primarily around MRV factories. 
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These authors proposed a mechanism for MRV prevention of host cell translational shutoff in 
which the diffuse localization of 3 in some strains results in inhibition of PKR activation 
throughout the cell, and subsequent release of both cellular and viral translation from PKR 
inhibition. Alternatively, these authors suggested that the localization of 3 predominantly in 
viral factories in strains that cannot prevent shutoff results in inhibition of PKR activation in 
these areas only (where MRV translation may take place), resulting in the shutoff of cellular 
translation by active PKR elsewhere in the cytoplasm (34). While strong evidence supports a 
role for 3 in modulating the ability of MRV to prevent host cells from shutting off protein 
translation in response to infection, the mechanism behind the ability of viral mRNAs to 
escape translational shutoff and continue translating mRNA in MRV strains that cannot 
prevent shutoff remains poorly understood.  
A number of recent studies have illustrated the downstream consequences of eIF2  
phosphorylation on mRNA and the cellular translation machinery. As described above, 
phosphorylation of eIF2  results in a reduction in the availability of ternary complex, leading 
to an increase in 48S pre-initiation complexes that are unable to recruit 60S ribosomal 
complexes for translation initiation. This destabilization of polysomes leads to the rapid 
localization of mRNAs, translation initiation factors, and small, but not large, ribosomal 
subunits to discrete structures in the cytoplasm called stress granules (SGs) (8, 9, 12).  A 
number of proteins, such as TIAR/TIA-1 and G3BP, all of which have RNA-binding and 
self-aggregation domains, have been identified that play key roles in the formation and 
recruitment of protein and RNA components to SGs. Importantly, SGs are not seen in cells 
growing in favorable conditions, but form during times of cellular stress including heat 
shock, oxidative stress, UV irradiation, and upon infection by many viruses (3, 9, 20, 21, 29, 
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38). eIF2  phosphorylation is sufficient to induce SGs, however, drugs that inhibit ribosome 
recruitment to initiation complexes (hippouristinol, pateamine A, 15D-PGJ2) downstream of 
ternary complex recruitment, have also been shown to induce SG formation independent of 
eIF2  phosphorylation (2, 11, 18).  SGs appear to serve as sites of mRNA triage that monitor 
the cellular environment to determine if a cell will undergo repair or apoptosis (8).    
We have recently shown that MRV infection induces formation of SGs in an eIF2α 
phosphorylation dependent manner at a step following virus uncoating, but preceding viral 
gene expression (28). In the previous study, we found that as MRV infection proceeds, SGs 
are disrupted in a manner that is dependent on viral translation, suggesting that a viral 
protein, or protein complex may be involved in SG disruption.  Initial induction and 
subsequent disruption of SGs during viral infection has been reported in a number of viral 
systems.  Some mechanisms for dispersing SGs have been identified.  For example, SG 
formation following West Nile virus infection occurs by TIAR/TIA-1 binding to the 3  stem 
loop of negative strand viral RNA (3).  Alternatively, poliovirus prevents SG formation by 
cleaving G3BP with the viral 3C proteinase (43). A number of other viruses, including 
Semliki Forest Virus (20) and rotavirus (22) also interfere with SG formation, although the 
mechanisms for this interference remain to be identified. In this study, we examined the step 
at which MRV is able to disrupt SGs and found that the disruption occurs downstream of 
eIF2  phosphorylation. We further examined the impact of SGs on viral and cellular 
translation in the absence and presence of eIF2  phosphorylation in uninfected and infected 
cells, and found that SG disruption correlates with release of viral, but not cellular mRNA 
from host translational inhibition, and that MRV translation occurs in the presence of high 
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levels of phosphorylated eIF2 that are inhibitory to cellular translation in a manner 
independent of PKR inhibition.  
Materials and methods  
Cells and reagents. HeLa, Cos-7, PKR+/+, and PKR-/- cell lines were maintained in DMEM 
(Dulbecco's modified Eagle's medium, Invitrogen Life Technologies) containing 10% fetal 
calf serum (Atlanta Biologicals) and penicillin/streptomycin (100 IU/mL, Mediatech). 
Spinner adapted L929 cells were maintained in c-MEM (Joklik's minimal essential medium, 
Irvine Scientific) containing 2% fetal calf serum and 2% fetal bovine serum (HyClone 
Laboratories, Atlanta Biologicals), 2 mM L-Glutamine (Mediatech) and 
penicillin/streptomycin (100 IU/mL, Mediatech). Primary antibodies used in 
immunofluorescence and immunoblotting assays are as follows: goat polyclonal -TIAR 
antibody (Santa Cruz Biotechnology), rabbit polyclonal -eIF2  antibody (Bethyl 
Laboratories), rabbit polyclonal -phospho-eIF2 Ser51) antibody and rabbit anti- -actin 
(Cell Signaling Technologies). Rabbit polyclonal antiserum against NS was made by the 
Iowa State University Hybridoma facility by injection of rabbits with peptides corresponding 
to NS AA 1-20, and NS AA 21-40 synthesized on a Multiple Antigen Peptide System 
(MAPS). Secondary antibodies used in immunofluorescence and immunoblotting 
experiments are as follows:  Alexa 488-, Alexa 594-, or Alexa 350-conjugated donkey -
mouse, -rabbit or -goat IgG antibodies (Invitrogen), and alkaline phosphotase-conjugated 
goat -rabbit IgG antibodies (Bio-Rad Laboratories). Sodium arsenite (Sigma-Aldrich) was 
used where indicated at a final concentration of 0.5 mM. Cycloheximide (Sigma-Aldrich) 
was used where indicated at a final concentration of 10 g/ml. 15D-PGJ2 (Sigma-Aldrich) 
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was used where indicated at a final concentration of 50 M. Alkaline phosphatase-
conjugated streptavidin (Invitrogen) and Alexa 488-conjugated streptavidin (Invitrogen) were 
used at 1:1000 and 1:100 dilutions respectively.  
Virions. Purified MRV virions (T1L, T3D
C
, T3D
N
, T2J strains) are our laboratory stocks. 
Purified virions were prepared as described (23) and stored in dialysis buffer (150 mM NaCl; 
10 mM Tris pH 7.4; 10 mM MgCl2) at 4 °C.  
Viral infection. 2.0 × 10
5
 (4.0 × 10
5
) cells were seeded onto 35 (60) mm dishes the day 
before transfection or infection. Cells were infected with MRV strains T1L, T2J or T3D
C
 at 
100 PFU/cell or 1000 PFU/cell as indicated in each experiment.  Virus was diluted in PBS + 
2 mM MgCl2, and adsorbed to cells for 1 h, at which point, cells were refed with DMEM and 
incubated at 37°C until harvested. 
L-azidohomoalanine (AHA) protein labeling. For in situ translation, Cos-7 cells were 
seeded on 12-well dishes containing 12-mm-diameter round coverslips at a density of 1x10
5
 
cells/well, incubated overnight at 37°C, then infected with MRV or mock infected. At 
indicated times p.i., medium was replaced with prewarmed methionine-minus medium 
containing sodium arsenite, cycloheximide, or 15D-PGJ2 at indicated concentration for 30 
min at which point AHA was added at a final concentration of 50 M, and cells were 
incubated for an additional 30 min. Cells were fixed with 100% ice cold methanol at -20°C 
for three min, then washed three times with PBS [137 mM NaCl, 3 mM KCl, 8 mM 
Na2HPO4 (pH 7.5)]. Fixed cells were permeabilized by incubation with 0.2% Triton X-100 in 
PBS for 5 min, and washed three times with PBS. Slides were transferred, cell side up to 
parafilm, and incubated with reagents provided for biotin labeling from Invitrogen. 
Alterations to the protocol provided by the manufacturer are as follows.  For each reaction, 
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25 l of Component A+B was added to 15 l PBS, and 40 l of this solution was added to 
coverslips.  2.5 l of Component C was added to coverslips, followed by 2.5 l of 
Component D, and 5 l of Component E.  Coverslips were incubated in this solution for 20 
min, then rinsed and processed for immunofluorescence.  For Western blot assays, Cos-7 
cells were seeded on 6 well dishes at a density of 2 × 5
5
 cells/well, then incubated overnight 
at 37°C, and infected with MRV or mock infected. At indicated times p.i., old medium was 
replaced with pre-warmed methionine-minus medium containing sodium arsenite, 
cycloheximide, or 15D-PGJ2 at indicated concentrations for 45 min at which point AHA was 
added at a final concentration of 50 M, and cells were incubated an additional 1 h.  Cells 
were harvested and lysed with 1% SDS in 50 mM Tris-HCl pH 8.0 and then AHA labeled 
nascent proteins were further conjugated with biotin as described in the manual with the 
following alterations. For each reaction, 30 l of Component A+B was added to 50 l of cell 
lysate previously label with AHA, followed by 5 l of Component C, 5 l Component D, and 
10 l of Component E.    Cells were then incubated, rotating end over end for 20 min. 
Following labeling, proteins were precipitated, resuspended in protein loading buffer, and 
separated on SDS-PAGE. 
Immunofluorescence (IF) assay. At indicated times p.i., cells were fixed at room 
temperature for 10 min with 2% paraformaldehyde in PBS or 100% methanol for 3 min and 
then washed three times with PBS. Fixed cells were permeabilized by incubation with 0.2% 
Triton X-100 in PBS for 5 min and then washed for three times with PBS. Samples were 
blocked by a 10 min incubation with 2% BSA in PBS. Primary and secondary antibodies 
were diluted in 2% BSA in PBS. After blocking, cells were incubated for 1 hour with 
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primary antibodies and Streptavidin conjugated Alexa 488, washed three times with PBS, 
and then incubated for an additional hour with secondary antibodies. Immunostained cells 
were washed for a final three times with PBS, and mounted on slides with Prolong reagent 
with or without DAPI (Invitrogen). Immunostained samples were examined with a Zeiss 
Axiovert 200 inverted microscope equipped with fluorescence optics. Images were prepared 
by using Photoshop and Illustrator software (Adobe Systems). 
Immunoblotting. Infected cells were harvested at different time points p.i., and lysed with 
100 l lysis buffer (50 mM Tris pH 8.0, 1% SDS). Protein concentrations for each sample 
were measured by EZQ
®
 protein quantitation Kit (Invitrogen), and equivalent amounts of 
protein from each sample were separated on SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). Proteins were transferred to a nitrocellulose membrane by electroblotting in transfer 
buffer [25 mM Tris, 192 mM glycine, 20% methanol (pH 8.3)]. The nitrocellulose containing 
transferred proteins was blocked for 15 min with 5% BSA in Tris-buffered saline (20 mM 
Tris, 137 mM NaCl [pH 7.6]) containing 0.1% Tween (TBS-T) and then incubated overnight 
with primary antibodies in TBS-T containing 1% milk or AP-conjugated streptavidin. Blots 
incubated with primary antibodies were washed three times for 15 min with TBS-T, followed 
by a 4 h incubation with AP-conjugated secondary antibodies in TBS-T containing 1% milk. 
Blots were washed for a final three times and AP conjugate substrates (Biorad) were applied 
to develop color.  
Results 
Despite high levels of eIF2  phosphorylation, SGs are not present in MRV infected cells 
at late times post-infection. We have previously shown that MRV infection induces SGs at 
early times (2-4 h) post-infection in an eIF2α phosphorylation-dependent manner. We 
94 
 
 
 
additionally found that as infection proceeds, SGs are disrupted in infected cells in a manner 
dependent on viral gene expression. To begin to examine the step at which MRV disrupts 
SGs, we first examined SG formation and the phosphorylation status of eIF2α at late times in 
MRV infected cells. L929, Cos-7, and Hela cells were infected with MRV (strains T1L, T2J, 
and T3D
C
) and at 24 h p.i., were fixed, permeabilized, and immunostained with - NS and 
-TIAR to visualize infected cells and SGs, respectively. Consistent with our earlier studies, 
we found that in L929 (Fig. 1A), Cos-7 (Fig. 1B), or HeLa (Fig. 1C) cells there are no SGs at 
late times in either uninfected cells, or in T1L (second row), T2J (third row), or T3D
C
 
(bottom row) infected cells that are expressing high levels of viral protein.  On the contrary, 
in control cells treated with sodium arsenite (SA), an oxidative substance that induces high 
levels of eIF2α phosphorylation via activation of the HRI kinase, 99% of cells contained SGs 
(Figs. 1A, 1B, and 1C, top rows).  
eIF2α phosphorylation is required for MRV induction of SGs at  early times in 
infection, and has been found to be sufficient for SG induction in cells. Although it has been 
reported previously that MRV infected cells contain high levels of phosphorylated eIF2α, it 
was possible that SGs are disrupted in MRV infected cells as viral infection continues 
because eIF2α phosphorylation is diminished at later times in infection. To examine this 
possibility, we measured the relative levels of eIF2α phosphorylation versus total eIF2α by 
performing immunoblots on cell lysates harvested from untreated- and SA-treated mock 
infected cells, and MRV infected cells at 24 h p.i. We found that infection with all three 
strains of MRV led to an increase in induction of eIF2α phosphorylation compared with 
mock infected cells, with T2J inducing levels of eIF2α phosphorylation similar to SA-
treatment in all cell types, and T1L and T3D
C
 inducing varying increases in eIF2α 
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phosphorylation (Fig. 1D).  MRV strain- and host cell- specific differences in eIF2α 
phosphorylation induction are consistent with previously published results (16). As we did 
not detect SGs in any tested cell lines with the three prototype MRV strains at these times 
p.i., this data suggests that at late times in infection, MRV disrupts the pathway between 
eIF2α phosphorylation and SG formation.    
MRV infection renders cells unable to form SGs in response to strong external stress 
signals. The absence of SGs in MRV infected cells suggested that MRV is able to uncouple 
eIF2  phosphorylation from SG induction.  However, it was also possible that levels of 
phosphorylated eIF2  induced by MRV were not sufficient to induce SGs in infected cells.  
To further examine the capacity of MRV to prevent SG formation in response to stress 
signals, we examined uninfected and infected cells for SG formation following sodium 
arsenite treatment. Cos-7 cells were infected with MRV strains T2J or T3D
C
, then at 19 h 
p.i., cells were treated with sodium arsenite for 1 h, then fixed and stained for 
immunofluorescence microscopy using antibodies against non-structural protein NS to 
visualize infected cells, and antibodies against TIAR to visualize SGs.  Remarkably, while 
SGs were apparent in all uninfected cells, infected cells did not contain SGs (Fig. 2A, B, C). 
This experiment was repeated using other known SG localized protein markers, including 
TIA-1, eIF3, eIF4E, and eIF4G, with identical results (data not shown). This finding was 
both viral strain and cell type independent as all three prototype strains (T1L, T2J, and T3D) 
interfered with SG formation in a number of cell types including Cos-7, CV-1, HeLa, L929, 
and MEFs (Fig. 2 A, B, and C, and data not shown). These findings confirm that MRV 
actively interferes with the cellular stress response by disrupting or preventing SG formation. 
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MRV SG interference is downstream of eIF2  phosphorylation. Because both 
MRV infection and sodium arsenite treatment induce eIF2  phosphorylation, our data 
suggested that MRV interference with SG formation at late times in infection occurs in the 
presence of phosphorylated eIF2α, however, it remained possible that in MRV-infected cells, 
SGs are prevented by viral interference with phosphorylation of eIF2 .  We used two 
additional assays to rule out this possibility.  First, we examined the levels of phosphorylated 
eIF2α in MRV-infected versus uninfected cells upon addition of SA.  At 19 h p.i., MRV 
(T1L, T2J, T3D
C
) and mock infected cells were subjected to SA for 1 h, then cells were 
harvested.  Proteins were separated on SDS-PAGE, transferred to nitrocellulose, then 
immunoblotted with antibodies against viral non-structural protein NS, total eIF2α and 
phosphorylated eIF2α.  Relative fold-increases in the level of eIF2α phosphorylation in the 
absence and presence of SA treatment were calculated using chemiluminscence.  We found 
that SA induced eIF2α phosphorylation to similar levels in infected and uninfected cells (Fig. 
3A). Because SGs do not form in response to SA treatment in MRV-infected cells at this 
time p.i. (Fig. 2), this suggests MRV interference with SGs is downstream of eIF2α 
phosphorylation.   
We also examined the ability of MRV to interfere with SGs induced by NSC119893, 
and 15D-PGJ2, both of which induce SGs independently of eIF2α phosphorylation.  
NSC11983 binds to eIF2α and inhibits ternary complex formation, and 15D-PGJ2 binds to 
eIF4A, and inhibits translation initiation.  Cos-7 cells were infected, and at 19 h p.i., cells 
were treated with NSC11983 or 15D-PGJ2 for 1 h, then fixed, permeabilized, and stained 
with antibodies against mNS and TIAR to visualize infected cells and SGs.  We found that 
MRV infection was able to completely interfere with SGs induced by these drugs, confirming 
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that the prevention of SG-formation by MRV does not occur as a result of interference with 
eIF2α phosphorylation (Fig. 3B).  These data confirm that MRV interference with SG 
formation occurs at some point downstream of eIF2α phosphorylation.  Taken together with 
our previously published data showing that SGs are disrupted in a manner requiring the 
expression of viral proteins, these data support a hypothesis that a viral protein or 
nucleoprotein complex is involved in disruption/prevention of SGs in the presence of eIF2  
phosphorylation in MRV-infected cells.   
Development of a non-radioactive protein labeling strategy for in situ detection of newly 
translated proteins.  In order to examine the role of SG disruption in MRV escape from host 
cell translational shutoff, we next developed a method to examine individual cells to 
determine if the presence of SGs interfered with new protein translation, as well as to 
examine total viral and cellular protein translation. We took advantage of a new 
commercially available technology, Click-iT AHA (Invitrogen), that utilizes click chemistry 
to label proteins as they are being synthesized.  This technology utilizes a methionine 
analogue (L-azidohomoalanine) that is added to cells and incorporated into proteins as they 
are translated.  Proteins are then subjected to biotin-labeled alkyne and a copper catalyst, 
which results in biotin-labeling of proteins that were synthesized during the L-AHA labeling 
period (Fig. 4A).  We manipulated this system so that labeled proteins could be detected 
using immunofluorescence assays (Fig. 4B), or Western blot (Fig. 4C) using Alexa 488-, or 
alkaline phosphatase-conjugated streptavidin respectively.   
MRV and cellular translation are inhibited when SGs are present in sodium arsenite-
treated cells at early times post-infection. In order to examine the effect of SGs on viral 
translation, we needed to create an environment in which MRV mRNAs were being actively 
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translated to levels that we could measure in our assays, but where amounts of MRV protein 
were not yet high enough to prevent SG formation. We reasoned that if we treated cells with 
sodium arsenite at 5-6 h p.i., MRV-induced SGs would already be disrupted, and viral 
protein synthesis would be initiated, but that the limited amounts of viral protein present at 
these times would not be sufficient to interfere with SG formation induced by sodium 
arsenite.  
To visualize protein synthesis on an individual cell basis, Cos-7 cells were infected 
with MRV and at 5 h.p.i., cells were left untreated, or were treated with sodium arsenite or 
cycloheximide, then labeled with AHA.  After labeling, cells were fixed, permeabilized, and 
subjected to a biotin alkyne click reaction.  Cells were stained with virus and SG specific 
antibodies, or Alexa 488-conjugated streptavidin, then examined by immunofluorescence 
microscopy for MRV infection, SG formation, and new protein synthesis. In this assay, both 
uninfected and infected untreated cells were found to synthesize new proteins during the 
labeling period (Fig. 5A, top row).  Cycloheximide, which inhibits translation at the 
elongation step, inhibited translation of new proteins in both infected and uninfected cells 
(Fig. 5A, middle row).  At this early time point in infection, sodium arsenite induced SGs in 
both uninfected and infected cells (Fig. 5A, bottom row). Upon examination of individual 
cells, we found that both uninfected and infected cells contained SGs, and that in the 
presence of SGs, neither uninfected nor infected cells were able to support new protein 
synthesis (Fig. 5A, bottom row).  
To examine the entire population of cells, these experiments were repeated. However, 
instead of performing immunofluorescence after AHA-labeling, proteins were harvested and 
labeled with biotin.  Labeled proteins were separated on SDS-PAGE, transferred to 
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nitrocellulose, then blotted with alkaline phosphatase-conjugated streptavidin to visualize 
new protein synthesis.  Similar to what was seen on an individual cell basis, new cellular and 
viral protein synthesis were detected in both uninfected and infected untreated cells, but 
cycloheximide and SA strongly inhibited both cellular and viral translation (Fig. 5B).  These 
results confirmed that SA induction of eIF2α phosphorylation results in the inhibition of both 
cellular and viral translation at early times in MRV-infected cells in a manner that correlates 
with the presence of SGs in cells.  
Viral, but not cellular, mRNAs escape eIF2α phosphorylation induced translational 
shutoff when SGs are disrupted at late times post-infection. SGs were not observed at late 
times in MRV infection irrespective of high levels of eIF2α phosphorylation induced by the 
virus or by SA. To determine whether viral or cellular proteins are synthesized at late times 
when SGs are disrupted by the virus, at 20 h p.i. Cos-7 cells were left untreated, or were 
treated with cycloheximide or sodium arsenite. Cells were labeled with AHA, then fixed, 
permeabilized, and subjected to a biotin click reaction. Labeled cells were stained with virus- 
and SG-specific antibodies, or Alexa 488-conjugated streptavidin, then examined by 
immunofluorescence microscopy for MRV infection, SG formation, and new protein 
synthesis. In the absence of drugs, both uninfected and infected cells were found to 
synthesize new proteins during the labeling period (Fig. 6A, top row). Cycloheximide 
inhibited translation of new proteins in both infected and uninfected cells (Fig. 6A, middle 
row).  Similar to what was seen at early times p.i., in the presence of SA, uninfected cells 
contain SGs and cannot support new protein synthesis.  In contrast, MRV infected cells do 
not contain SGs, and only these cells are capable of supporting protein synthesis in the 
presence of the high levels of eIF2α phosphorylation induced by SA (Fig. 6A, bottom row).   
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While this result shows that protein synthesis is active only in MRV infected cells 
that do not contain SGs, it does not determine if MRV disruption of SGs correlates with 
release of all protein translation inhibition, or if just viral mRNA is translated under these 
conditions.  To answer this question, we repeated these experiments. However, instead of 
visualizing proteins by fluorescence microscopy, we separated labeled proteins on SDS-
PAGE, transferred them to nitrocellulose, and blotted with alkaline phosphatase-conjugated 
streptavidin.  Examination of the proteins synthesized in the absence and presence of drugs 
on the Western blot confirmed that SA induced near complete shutoff of cellular protein 
synthesis in the absence of MRV infection (Fig. 6B, left panel), and further, that only 
proteins that migrated at the size of MRV proteins ( , , ) were translated in the presence of 
SA in MRV infected cells (Fig. 6B, right panel). We confirmed that proteins translated in the 
presence of SA in MRV infected cells were viral by immunoblotting the same membrane 
with virus protein-specific antibodies (data not shown).  Taken together with data obtained at 
early times p.i., these data suggest that MRV and cellular translation are inhibited in the 
presence of high levels of phosphorylated eIF2α when SGs are present, but that at late times 
in infection, even though high levels of eIF2α remain phosphorylated, disruption of SGs by 
MRV correlates with escape of viral, but not cellular mRNA, from host cell translational 
shutoff. 
MRV translation is inhibited by 15D-PGJ2 at early times post-infection when SGs are 
present in cells. The addition of SA to cells induces the phosphorylation of eIF2α and SG 
formation (10).  Although somewhat controversial, it has previously been reported that MRV 
mRNAs that are synthesized at early times in infection contain a 5’ cap structure, whereas 
those synthesized at late times are uncapped (45).  Therefore, it was possible that our above 
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data suggested that at early times in infection, MRV mRNAs are capped, and cannot escape 
translational inhibition that occurs as a result of phosphorylation of eIF2α, but that at late 
times in infection MRV mRNAs are not capped and can escape this shut off, irrespective of 
SG presence in the cell.  To uncouple eIF2α phosphorylation from SG formation in cells, we 
next examined whether the eIF4A inhibitor, 15D-PGJ2, which induces SGs, but does not 
induce eIF2α phosphorylation (11), inhibits viral translation at early times p.i. Cos-7 cells 
were infected, and at 5 h p.i., cells were either left untreated, or treated with cycloheximide 
or 15D-PGJ2. Cells were then labeled with AHA in the presence of drugs, subjected to the 
biotin alkyne click reaction, stained with virus- and SG-specific antibodies, or Alexa 488-
conjugated streptavidin, and examined by immunofluorescence microscopy. In the absence 
of drugs, both uninfected and infected cells were translationally active (Fig. 7A, top row), 
and in the presence of cycloheximide, neither uninfected nor infected cells were 
translationally active (Fig. 7A, middle row).  In the presence of 15D-PGJ2, uninfected cells 
contained SGs, and did not contain newly synthesized proteins (Fig. 7A, bottom row). 15D-
PGJ2 also induced SGs in many, but not all, MRV infected cells at this time p.i., and in 
infected SG-containing cells, no new protein synthesis was observed (Fig. 7A, bottom row).  
Some MRV infected cells did not contain SGs in response to 15D-PGJ2, likely because these 
cells were expressing sufficient levels of viral protein to prevent SG formation when the drug 
was added. In infected cells that did not contain SGs, new protein synthesis was observed 
(data not shown).  
To visualize the impact of 15D-PGJ2 treatment on translation of the entire cell 
population, we labeled cells in the absence and presence of drugs, and harvested total 
proteins.  Proteins were subjected to a biotin alkyne click reaction, separated on SDS-PAGE, 
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and transferred to nitrocellulose. AP-conjugated streptavidin was used to visualize new 
protein synthesis.  In these experiments, 15D-PGJ2 prevented host cell protein translation in 
uninfected cells, and inhibited viral protein translation in infected cells (Fig. 7B). As we 
noted in immunofluorescence assays, 15D-PGJ2 did not completely inhibit viral translation 
in these experiments. Similar to our imumunofluorescence data, we suggest that viral 
translation that escapes 15D-PGJ2 inhibition in these experiments occurs in MRV infected 
cells that are expressing sufficient viral protein such that SG formation is prevented 
following 15D-PGJ2 treatment at this time p.i. These data suggest SG interference with 
MRV translation is independent of eIF2α phosphorylation. 
MRV but not cellular mRNAs escape 15D-PGJ2-induced translational shutoff when 
SGs are disrupted at late times in infected cells. To further separate the effect of SGs from 
the effect of eIF2α phosphorylation on viral translation, we examined the impact of 15D-
PGJ2 on cellular and viral translation at late times in MRV infection using the same 
experiments that was done at 5 h p.i. In the absence of drugs, both uninfected and infected 
cells were found to synthesize new proteins during the labeling period (Fig. 8A, top row). 
Cycloheximide inhibited translation of new proteins in both infected and uninfected cells 
(Fig. 8A, middle row).  Similar to what was seen at early times p.i., in the presence of 15D-
PGJ2, uninfected cells contained SGs and were not synthesizing new proteins (Fig. 8A, 
bottom row). In contrast, MRV infection interfered with 15D-PGJ2 induction of SGs, and 
infected cells were capable of supporting new protein synthesis (Fig. 8A, bottom row).  
In order to confirm these findings, we repeated these experiments and harvested total 
proteins.  Proteins were labeled with biotin alkyne, separated on SDS-PAGE, and transferred 
to a nitrocellulose membrane. When the membrane was blotted with alkaline phosphatase-
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conjugated streptavidin, we found that 15D-PGJ2 completely inhibited cellular protein 
synthesis in uninfected cells, but did not inhibit viral protein synthesis in infected cells (Fig. 
8B). We also confirmed that 15D-PGJ2 treatment did not increase the levels of 
phosphorylated eIF2α in infected and uninfected cells, compared with untreated samples 
(Fig. 8B).  These results indicate that MRV interference with SG formation following 15D-
PGJ2 treatment correlates with virus escape from host cell translational shutoff, and further, 
suggest that it is the presence of SGs and not eIF2α phosphorylation that inhibits MRV 
translation at early times in infection. 
MRV escape from host translation inhibition is independent of PKR. It was previously 
reported that there is a strain specific difference in the ability of MRV to induce host cell 
shutoff, with infection by most MRV strains inducing eIF2α phosphorylation and subsequent 
shutoff of host cell translation while infection with some MRV strains does not (39). Using 
reassortant genetics, this difference in induction of host cell shutoff was mapped to the MRV 
dsRNA binding protein 3, supporting a hypothesis where 3 binds dsRNA, inhibiting PKR 
phosphorylation of eIF2 , and preventing host cell shutoff (15). While it is clear that 3 
plays an important role in prevention of host translational shutoff, it remains unclear if 3 
inhibition of PKR plays a role in MRV mRNA escape from cellular translational shutoff in 
viral strains that do not interfere with shutoff.  Because we consistently found that MRV 
translation was able to escape SA-induced translational shutoff, which occurs through HRI 
kinase phosphorylation of eIF2 , and not PKR phosphorylation of eIF2 , we suspected that 
MRV escape from virus induced translational shutoff may be independent of 3 inhibition of 
PKR.  To determine if PKR was necessary for MRV translational escape from SA induced 
eIF2α phosphorylation, we infected PKR+/+ and PKR-/- cells with MRV and at 20 h p.i., 
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cells were treated with cycloheximide or SA, and labeled with AHA.  Proteins were 
harvested and subjected to a biotin alkyne click reaction, separated on SDS-PAGE then 
transferred to nitrocellulose, which was blotted with AP-conjugated streptavidin. In PKR+/+ 
cells, untreated uninfected and infected cells were translationally active (Fig. 9).  In 
cycloheximide treated uninfected and infected cells, both viral and cellular translation were 
inhibited.  In SA treated cells, cellular, but not viral, translation was inhibited (Fig. 9).  In 
PKR-/- cells we found essentially identical results, with viral translation escaping SA-
induced translational shutoff (Fig. 9), strongly suggesting that MRV translation can escape 
phospho-eIF2α-induced host cell translational inhibition independent of 3 inhibition of 
PKR. 
Discussion 
MRV disrupts SGs in infected and drug-treated cells downstream of eIF2  
phosphorylation. We recently reported cells form SGs in response to MRV infection at early 
times post-infection in an eIF2 -phosphorylation dependent manner, and that SGs are 
disrupted as viral proteins accumulate in a manner that is dependent on viral protein synthesis 
(28).  In this work, we show that in addition to disrupting SGs over time in infected cells, 
MRV also prevents SG formation following treatment with SG-inducing drugs SA and 15D-
PGJ2.  The disruption/prevention of SGs in infected and SA-treated cells was found to occur 
in the presence of high levels of eIF2  phosphorylation.  Disruption of SGs induced by 15D-
PGJ2 clearly is independent of interference with eIF2  phosphorylation, because this drug 
induces SGs independent of eIF2  phosphorylation. These data support a hypothesis where 
MRV encodes a protein or nucleoprotein complex that actively disrupts or interferes with SG 
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formation, perhaps by direct or indirect interference with SG effecter protein aggregation.  
Other viruses have been shown to encode viral factors that actively disrupt SGs by interfering 
with SG effecter proteins. Poliovirus protease 3C specifically cleaves G3BP resulting in SG 
disruption (43), and West Nile virus RNA binds TIAR/TIA-1 proteins which are recruited to 
viral replication centers, ultimately resulting in SG disruption (3). Other viruses such as 
Sindbis virus and rotavirus also disrupt SGs in the presence of eIF2  phosphorylation (42), 
although the mechanism has not been determined. The identification of an MRV component 
involved in SG disruption is currently underway. 
SG disruption correlates with MRV escape from host translational shutoff.  Because 
SGs participate in sequestration of translation initiation factors following cellular stress (12), 
they are likely to take part in the inhibition of translation that occurs following infection with 
many viruses.  It therefore seems likely that viruses have developed ways to disperse SGs to 
release translation initiation factors that are necessary to carry out viral protein synthesis.  
Although many viruses have been shown to disrupt SGs, most studies have not yet delineated 
the importance of SG disruption on successful viral infection.  It has been shown that some 
viruses, such as VSV, Sindbis virus, and HSV, replicate better in TIA-1-/- cells, which are 
deficient in the ability to form SGs, suggesting that the function of SGs in translation 
inhibition may be detrimental to successful virus infection (14). In the case of poliovirus, it 
was found that the ability of the virus protease to disrupt SGs via G3BP cleavage was 
important for successful virus infection, as expression of a non-cleavable G3BP inhibited 
poliovirus replication (43). Additionally, the binding of TIAR/TIA-1 to West Nile virus RNA 
disrupts SGs and also appears to promote viral RNA replication, though it has yet to be 
shown that SG disruption per se plays an important role in this process (14).  In this work, we 
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provide evidence that in the case of MRV, SG disruption is an important step in virus 
circumvention of the host immune response by demonstrating that MRV translation is 
inhibited when SGs are present, but not inhibited when SGs are disrupted by the viral 
infection. Correlation between the release of MRV mRNAs from translation inhibition and 
SG disruption occurred in the presence of phosphorylated eIF2  and when eIF4A was 
inhibited, bolstering the argument that SGs themselves impact viral translation. 
MRV translation occurs in the presence of phosphorylated eIF2  and when eIF4A is 
inhibited.  Although our data supports a hypothesis that SGs play some role in regulation of 
MRV translation, and SG disruption appears to coincide with viral RNA escape from cellular 
translational inhibition, it is not likely that SG disruption is sufficient for viral mRNA 
translation in the stressed environment. An obvious question that arises, is how MRV 
mRNAs are able to compete for the limited ternary complex that is available in the cell when 
eIF2  is phosphorylated following infection, or SA treatment. A possibility that we are 
considering is that MRV translation is refractory to a high concentration of phosphorylated 
eIF2  as a result of an unidentified alternative translation initiation pathway. Many viral and 
cellular mRNAs contain specialized structures or elements within their sequence that allow 
them to be preferentially translated in an environment of high levels of phosphorylated 
eIF2 . These can include certain IRESs, such as that found in Hepatitis C virus RNA which 
recruits eIF2  and tRNA
Met
 independently of ternary complex (30, 40), upstream ORFs 
(uORFs), which induce ribosome stalling that leads to preferential translation of some stress-
related mRNAs such as ATF4 (41), and mRNAs that can recruit tRNA
Met
 independent of 
eIF2 , such as Sindbis virus 26S RNA (32).  It would not be completely surprising to learn 
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that MRV may have developed a non-canonical pathway for translation initiation because 
although MRV mRNAs do possess an m7pppG cap structure like cellular mRNAs, they do 
not possess a polyA tail, and therefore, may have differing mechanisms for initiation.  
Moreover, the fact that MRV protein synthesis was not inhibited by 15D-PGJ2 when SGs 
were disrupted also suggests that MRV mRNA translation occurs via an alternative pathway 
that is independent of eIF4A. A detailed examination of MRV translation, including 
identification of cellular translation initiation factors that are required, identification of viral 
proteins that are involved, and examination of viral RNA sequences to identify important 
sequences or structures is warranted in the future.  
MRV translation: role of 3 inhibition of PKR. Previous data implicated the MRV 3 
dsRNA binding protein in prevention of cellular translational shutoff following infection 
with some MRV strains (7). The MRV 3 protein has also been shown to functionally 
replace other viral PKR inhibitors when expressed in cells infected with these viruses (1). For 
these reasons, the PKR inhibition activity of 3 was suspected to also be involved in the 
ability of MRV mRNAs to escape translational shutoff in strains that could not prevent this 
cellular response to infection (34). Two lines of evidence from this study suggest that this is 
not the case.  First, irrespective of their host cell shutoff phenotype, all strains of MRV were 
able to continue translating mRNA in the presence of sodium arsenite at late times in MRV 
infection.  Because sodium arsenite induces eIF2  phosphorylation via the HRI kinase (19), 
and not PKR, any 3 mediated PKR inhibition would not impact eIF2  phosphorylation 
under these conditions. Moreover, we also show that sodium arsenite treatment of infected 
cells induces levels of eIF2  phosphorylation similar to those in mock infected cells, which 
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suggests that even if PKR is involved in sodium arsenite induction of eIF2  phosphorylation, 
3 is not significantly inhibiting PKR under these circumstances. Finally, we directly showed 
that MRV mRNA translation is not inhibited in the presence of sodium arsenite in PKR-/- 
cells, strongly suggesting that MRV inhibition of PKR is not involved in MRV escape from 
host translational shutoff.  Taken together, these data suggest that the ability of MRV to 
prevent host cell translational shutoff, and the ability of MRV mRNAs to escape host cell 
translational shutoff likely occur through independent mechanisms.   
A Model for the role of SGs in MRV infection.  Based on previous data and this study, we 
have developed a working model for the role of SGs and SG disruption during MRV 
infection.  In this model, when MRV infects cells, the cell attempts to inhibit viral replication 
by activation of PKR, phosphorylation of eIF2 , and formation of SGs. The presence of SGs 
inhibits viral translation, as is artificially shown by treatment of infected cells at this early 
time with sodium arsenite or 15D-PGJ2. However, there must be a delicate balance between 
SG formation and viral translation, as ultimately, the virus is able to disperse SGs as 
infection proceeds, and this ability is dependent on the accumulation of viral proteins in the 
cell.  At later times in infection, even though eIF2  is phosphorylated, SGs are no longer 
able to form in MRV infected cells. This ability to disrupt or prevent SG formation correlates 
with virus escape from translational inhibition, as is shown artificially by the ability of MRV, 
but not cellular mRNAs to be translated in cells following treatment with sodium arsenite or 
15D-PGJ2 only when the virus is capable of disrupting SGs.     
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Figure 1. Cells infected with MRV do not contain SGs at late times post-infection 
despite eIF2  phosphorylation. (A) L929 (B) Cos-7 and (C) HeLa cells were mock 
infected (top row, left), mock infected, then treated with sodium arsenite for 1 h prior to 
fixation (top row, right) or infected with MRV T1L (second row), T2J (third row), or T3D
C
 
(bottom row). At 20 h p.i., cells were fixed and immunostained with rabbit - NS polyclonal 
antiserum (second, third, and bottom rows, left column) and goat -TIAR polyclonal 
antibody (top row, left and right columns, second, third and bottom rows, right column), 
followed by Alexa 594- conjugated donkey -rabbit IgG and Alexa 488-conjugated donkey 
-goat IgG.  Bar=10 M. (D) L929, Cos-7, and HeLa cells were mock infected, mock 
infected and treated for 1 h with sodium arsenite prior to harvest, or infected with MRV T1L, 
T2J, or T3D
C
.  At 20 h p.i. cells were harvested and proteins were separated on SDS-PAGE, 
and transferred to nitrocellulose. Membranes were blotted with rabbit - NS, rabbit -
phosphorylated eIF2 , or rabbit -eIF2  polyclonal antibody, followed by goat -rabbit IgG 
conjugated with HRP. Bound HRP conjugates were detected by chemiluminescence staining, 
quantified by Quantity-One software, and levels of eIF2  phosphorylation in the sodium 
arsenite-treated mock, and infected cells relative to untreated mock cells were calculated and 
plotted on the graph.   
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Figure 2. MRV infection renders cells unable to form SGs in response to Sodium 
Arsenite.  (A) L929 (B) Cos-7 or (C) HeLa cells were infected with MRV T2J (top rows) or 
T3D
C
 (bottom rows). At 20 h.p.i., cells were treated with sodium arsenite for 1 hour, then 
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fixed and immunostained with rabbit - NS polyclonal antiserum (left colums) and goat -
TIAR polyclonal antibody (middle columns), followed by Alexa 594-conjugated donkey -
rabbit IgG and Alexa 488-conjugated donkey -goat IgG. Merged images containing DAPI-
stained nuclei (blue) are shown (right columns). Bar=10 M. 
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Figure 3. MRV interference of SGs is downstream of eIF2  phosphorylation. (A) Cos-7 
Cells were infected with MRV T1L, T2J or T3D
C
. At 20 h.p.i., cells were left untreated or 
treated with sodium arsenite for 1 hour.  Samples were harvested and proteins were separated 
on SDS-PAGE and electroblotted to nitrocellulose. Nitrocellulose membranes were then 
immunoblotted with rabbit - NS, rabbit -phosphorylated eIF2 , or rabbit -eIF2  
polyclonal antibodies as indicated, followed by goat -rabbit IgG conjugated with HRP. 
Bound HRP conjugates were detected by chemiluminescence and quantified with Quantity-
One software. Fold-increase in levels of phosphorylated eIF2  in sodium arsenite treated 
uninfected and infected cells relative to untreated cells were calculated and are shown. (B) 
Cos-7 Cells were infected with MRV T3D
C
 and at 20 h.p.i., cells were treated with either 
NSC11983 (top row) or 15D-PGJ2 (bottom row) for 1 hour, then fixed and immunostained 
with rabbit - NS polyclonal antiserum (left column) and goat -TIAR polyclonal antibody 
(right column), followed by Alexa 594-conjugated donkey -rabbit IgG  and Alexa 488-
conjugated donkey -goat IgG. Bar=10 M. 
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Figure 4. A non-radioactive protein labeling strategy for detection of newly translated 
proteins. (A) L-azidohomoalanine (L-AHA) is a methionine analog that is metabolically 
incorporated into nascent proteins as they are translated. Once L-AHA is incorporated, azide-
modified nascent proteins can be covalently linked to biotin-conjugated alkyne in a “click” 
reaction (Invitrogen Click-iT® AHA) (B) Cells grown on coverslips are infected with virus, 
incubated overnight, then treated with drugs as indicated.  L-AHA is added to cells and is 
incorporated into proteins that are being synthesized during the labeling period.  Nascent 
proteins are labeled with biotin in a click reaction and detected by Alexa 488-conjugated 
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streptavidin. (C) Cells grown on plastic dishes are infected with virus, incubated overnight, 
then treated with drugs as indicated.  L-AHA is added to cells and is incorporated into 
proteins that are being synthesized during the labeling period.  Nascent proteins are labeled 
with biotin in a click reaction, separated on SDS-PAGE and transferred to nitrocellulose, 
then detected by alkaline phosphatase (AP)-conjugated streptavidin.  
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Figure 5. Viral and cellular translation are inhibited when SGs are present in sodium 
arsenite-treated cells at early times post-infection. (A) Cos-7 cells were infected with T3D 
and at 5 h p.i., cells were left untreated, (top row) or treated with cycloheximide (middle row) 
or SA (bottom row) for 30 min, then L-AHA was added in the presence of the drugs for an 
additional 30 min.  Cells were fixed and permeabilized, labeled with biotin in a click 
reaction, then stained with Alexa 488-conjugated streptavidin to visualize nascent protein 
synthesis (middle column). Cells were additionally stained with antibodies against NS (left 
column) and TIAR (right column) followed by Alexa 350-conjugated donkey -rabbit IgG or 
Alexa 594 conjugated donkey -goat IgG antibody to visualize infected cells and stress 
granules. Bar=10 M. (B) Cos-7 cells were infected with T3D and were treated with drugs in 
A. 60 min following drug-treatment, L-AHA was added and cells were incubated for an 
additional 60 min. Cells were harvested and proteins were labeled with biotin in a click 
reaction, then separated on SDS-PAGE and transferred to nitrocellulose by electroblotting. 
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AHA-labeled proteins were detected by incubation of blots with AP-conjugated streptavidin.  
Identical sample volumes were examined in parallel using -actin-specific antibodies, 
followed by AP-conjugated goat -rabbit IgG as a protein loading control. 
  
124 
 
 
 
 
Figure 6. MRV, but not cellular, mRNAs escape eIF2α phosphorylation induced 
translational shutoff when SGs are disrupted at late times post-infection. (A) Cos-7 cells 
were infected with T3D and at 5 h p.i., cells were left untreated, (top row) or treated with 
cycloheximide (middle row) or SA (bottom row) for 30 min, then L-AHA was added in the 
presence of the drugs for an additional 30 min. Cells were fixed and permeabilized, labeled 
with biotin in a click reaction, then stained with Alexa 488-conjugated streptavidin to 
visualize nascent protein synthesis (middle column).  Cells were additionally stained with 
antibodies against NS (left column) and TIAR (right column) followed by Alexa 350-
conjugated donkey -rabbit IgG or Alexa 594 conjugated donkey -goat IgG antibody to 
visualize infected cells and stress granules. Bar=10 M.  (B) Cos-7 cells were infected with 
T3D and were treated with drugs in A.  60 min following drug treatment, L-AHA was added 
and cells were incubated for an additional 60 min.  Cells were harvested and proteins were 
labeled with biotin in a click reaction, then separated on SDS-PAGE and transferred to 
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nitrocellulose by electroblotting. AHA-labeled proteins were detected by incubation of blots 
with AP-conjugated streptavidin.  Identical sample volumes were examined in parallel using 
-actin-specific antibodies, followed by AP-conjugated goat -rabbit IgG as a protein 
loading control. 
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Figure 7. 15D-PGJ2 induces SGs and inhibits cellular and viral translation at early 
times post-infection. (A) Cos-7 cells were infected with T3D and at 5 h p.i., cells were left 
untreated, (top row) or treated with cycloheximide (middle row) or 15D-PGJ2 (bottom row) 
for 30 min, then L-AHA was added in the presence of the drugs for an additional 30 min.  
Cells were fixed and permeabilized, labeled with biotin in a click reaction, then stained with 
Alexa 488-conjugated streptavidin to visualize nascent protein synthesis (middle column).  
Cells were additionally stained with antibodies against NS (left column) and TIAR (right 
column) followed by Alexa 350-conjugated donkey -rabbit IgG or Alexa 594 conjugated 
donkey -goat IgG antibody to visualize infected cells and stress granules. Bar=10 M.  (B) 
Cos-7 cells were infected with T3D and were treated with drugs in A.  60 min following drug 
treatment, L-AHA was added and cells were incubated for an additional 60 min.  Cells were 
harvested and proteins were labeled with biotin in a click reaction, then separated on SDS-
PAGE and transferred to nitrocellulose by electroblotting. AHA-labeled proteins were 
detected by incubation of blots with AP-conjugated streptavidin.  Identical sample volumes 
127 
 
 
 
were examined in parallel using -actin-specific antibodies, followed by AP-conjugated goat 
-rabbit IgG as a protein loading control. 
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Figure 8. Viral but not cellular mRNAs escape 15D-PGJ2-induced translational shutoff 
when SGs are disrupted at late times in infected cells. (A) Cos-7 cells were infected with 
T3D and at 20 h p.i., cells were left untreated, (top row) or treated with cycloheximide 
(middle row) or 15D-PGJ2 (bottom row) for 30 min, then L-AHA was added in the presence 
of the drugs for an additional 30 min.  Cells were fixed and permeabilized, labeled with 
biotin in a click reaction, then stained with Alexa 488-conjugated streptavidin to visualize 
nascent protein synthesis (middle column).  Cells were additionally stained with antibodies 
against NS (left column) and TIAR (right column) followed by Alexa 350-conjugated 
donkey -rabbit IgG or Alexa 594 conjugated donkey -goat IgG antibody to visualize 
infected cells and stress granules. Bar=10 M.  (B) Cos-7 cells were infected with T3D and 
were treated with drugs in A.  60 min following drug treatment, L-AHA was added and cells 
were incubated for an additional 60 min.  Cells were harvested and proteins were labeled 
with biotin in a click reaction, then separated on SDS-PAGE and transferred to nitrocellulose 
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by electroblotting. AHA-labeled proteins were detected by incubation of blots with AP-
conjugated streptavidin.  Identical sample volumes were examined in parallel using total 
eIF2 - and phosphorylated eIF2 -specific antibodies, followed by AP-conjugated goat -
rabbit IgG as a protein loading control, and to examine the impact of 15D-PGJ2 on eIF2 -
phosphorylation. 
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Figure 9. SA does not inhibit MRV translation in PKR-/- cells at late times post-
infection. (A) PKR+/+ and PKR-/- cells were infected with T3D and at 20 h p.i. cells were 
left untreated or treated with cycloheximide or SA for 60 min at which point L-AHA was 
added and cells were incubated an additional 60 min.  Cells were harvested and proteins were 
labeled with biotin in a click reaction, then separated on SDS-PAGE and transferred to 
nitrocellulose by electroblotting. AHA-labeled proteins were detected by incubation of blots 
with AP-conjugated streptavidin.  Identical sample volumes were examined in parallel using 
-actin-specific antibodies, followed by AP-conjugated goat -rabbit IgG as a protein 
loading control. 
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Figure 10. A model for the role of SGs in MRV infected cells. Illustration diagramming 
the interplay between MRV and SGs throughout viral infection and in the presence of sodium 
arsenite and 15D-PGJ2. 
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Abstract 
Mammalian orthoreoviruses  escape from host translational shutoff in presence of increased 
levels of phosphorylated eIF2 . In order to understand the mechanism behind viral escape 
from host shutoff, we want to examine what factors (viral proteins, modifications of viral 
mRNA, or unique sequences of viral mRNA) are involved in viral translational escape from 
host shutoff by eIF2  phosphorylation. Here we recapitulated a 10-plasmid based reverse 
genetics system for mammalian othoreovirus strains (T1L and T3D) and established a 
platform to generate inducible viral protein-expressing cell lines in the background of L929 
cell line. Using this reverse genetics system and inducible cell lines, we expect to generate 
viral protein knockout mutants to test if viral proteins play a role in viral escape from host 
shutoff. We also expect to examine whether viral mRNA is involved in viral escape from 
host shutoff using several plasmid constructs which can be used to generate different mRNA 
sequences and L-AHA protein labeling technique as we described in the Chapter 4. Taken 
together, we laid an important groundwork for future study in viral escape from host 
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translational shutoff caused by eIF2  phosphorylation, which can potentially enhance our 
understanding of the oncolytic role of mammalian orthoreovirus in cancer therapy. 
Introduction 
       Reverse genetics is an approach for studying the functional role of specific gene 
sequences by directed deletion, point mutation, and gene silencing. Plasmid-based reverse 
genetic systems were developed for nearly all major groups of RNA- and DNA-containing 
viruses to study the functional roles of each gene in the viral genome. Reverse genetics 
systems allow artificial manipulation of viral genomes at the cDNA level by site-directed 
mutagenesis, deletion/insertion and rearrangement, and have led to the accumulation of a 
significant amount of new knowledge relating to the replication, biological characteristics 
and pathogenesis of these viruses. Members of the Reoviridae family contain a genome with 
10-12 individual segments of dsRNA. Viral mRNA is capped, but has no poly (A) tail (32). 
Reassortment experiments, which rely on the natural ability of genomic segments from 
different parental viruses to be packaged in progeny virus, have been utilized for the past 
three decades to “map” identified virus phenotypes to specific genes in the reovirus genome 
(10).  This genetic approach has contributed significantly to our understanding of viral entry 
and replication mechanism for members of the Reoviridae family (eg, reovirus, rotavirus). 
However, applications using this method are limited by the lack of ability to directly 
manipulate the gene of interest.  
Roner et al (1990) showed transfection of dsRNA or ssRNA from reovirus serotype 3 
into L929 cells with the help of deficient reovirus serotype 2 infection was able to rescue 
serotype 3 viruses (36). However, this method readily introduced unwanted reassortants, and 
was not well accepted in the field. Mundt et al (1996) reported that transfection of cells with 
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synthetic transcripts of a two-segmented double-stranded RNA virus, Birnavirus (Infectious 
Bursal Disease Virus, IBDV) was able to rescue virus without the use of helper viruses. Viral 
cDNA of IBDV was cloned into a plasmid downstream of bacteriophage T7 polymerase, 
viral RNAs were transcribed from linearized plasmids in vitro, and purified transcripts were 
used to rescue viruses from transcript-transfected cells (30). This reverse genetics system 
allowed manipulation of specific genes for two-segmented double stranded RNA viruses. 
Boot and Colleagues (1999) devised the first plasmid based reverse genetics system for two 
segmented dsRNA viruses (Birnaviruses) with the help of fowlpox virus expressing T7 
polymerase. They prepared plasmids carrying the full-length IBDV sequences of segment A 
and B, flanked by a bacteriophage T7 polymerase promoter and hepatitis delta virus (HDV) 
ribozyme and followed by a T7 RNA polymerase terminator. The HDV ribozyme gives the 
advantage that allows complete transcribed viral RNA sequence upstream of the cleavage site 
to be cut off by the ribozyme (3). Qi et al (2008) then reported rescue of IBDV from cDNA 
plasmids using a cellular polymerase II system (34), in which complete viral RNAs are 
synthesized by polymerase II, then cleaved by the hammerhead ribozyme at the 5’ termini 
and the hepatitis delta virus ribozyme at the 3’ termini to generate an identical copy of the 
virus RNAs. This approach does not need the introduction of a helper virus expressing T7 
polymerase which was used in previous strategies.  A simplified version of the polymerase II 
based reverse genetics strategy was then described for the rescue of viruses with high 
efficiency (10
11
 TCID50/ mL) (2). In this system, viral cDNAs were fused at the 5’ termini to 
the transcription start site of the immediate early cytomegalovirus promoter instead of using 
hammerhead ribozyme.  
Utilizing a system similar to that described for two-segmented viruses, a plasmid-
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based reverse genetics system was recently developed for mammalian orthoreovirus (19). 
Recombinant reovirus was rescued by transfecting 10 plasmids into murine L929 cells which 
were also co-infected with replication deficient vaccinia viruses expressing T7 RNA 
polymerase. In these plasmids, viral cDNAs are flanked by T7 polymerase promotor at 5’ 
termini, and by hepatitis delta ribozyme at 3’ termini. Recently, this method was further 
improved through the development of a four-plasmid reverse genetics system with much 
higher efficiency compared with his previous 10-plasmid based reverse genetics system (22). 
In this method, each of four plasmids contains more than two cDNAs from viral genomic 
segments, and are transfected into BHK (Baby Hamster Kidney) cells which constitutively 
expresses T7 RNA polymerase rather than using vaccinia viruses (22). Using this system, 
Kobayashi and his colleagues generated viable mutants and confirmed a number of 
previously published findings (11, 12, 19).  However, this 10 plasmid-based reverse genetics 
system is not sufficient to rescue virus mutants containing lethal defects.  
In order to study the functional roles of essential genes, cell lines expressing 
functional corresponding viral proteins have to be established to complement the current 
plasmid-based reverse genetics system for reovirus. Since overexpression of some viral 
proteins, such as 1, is lethal for cells, inducible cell lines expressing these viral proteins are 
required to complement the plasmid-based reverse genetics system. In this work, we have 
established an inducible L929 cell line for the expression of individual reovirus proteins.  We 
have performed proof of concept experiments that this cell line is capable of inducible 
expression of several reovirus proteins.  In addition, we have successfully recapitulated the 
ten-plasmid reverse genetics system for reovirus using T7 expressing BHK cells.   
This work has laid the foundation for a number of important studies aimed at 
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identifying the role of individual reovirus proteins in SG regulation, and in identifying viral 
protein and RNA sequences or structures involved in reovirus escape from host translational 
shutoff following virus induced eIF2  phosphorylation.  
Materials and methods  
Cells and reagents. Cos-7, cell lines were maintained in DMEM (Dulbecco's modified 
Eagle's medium from Invitrogen Life Technologies) containing 10% fetal calf serum 
(HyClone Laboratories) and penicillin/streptomycin (100 IU/mL) (Mediatech). Spinner 
adapted L929 cells were maintained in c-MEM (Joklik's minimal essential medium, Irvine 
Scientific) containing 2% fetal calf serum and 2% fetal bovine serum (HyClone 
Laboratories), 2 mM L-Glutamine and penicillin/streptomycin (100 IU/mL). BHK-T7 (Baby 
Hamster kidney cells constitutively expressing T7 polymerase)(7) were maintained in 
Glasgow’s MEM (Lonza) containing non-essential amino acids (Invitrogen), selected with 
G418 (100 g/ml) at every other passage. Primary antibodies used in immunofluorescence 
are as follows: Rabbit polyclonal antiserum against NS was made by the Iowa State 
University Hybridoma facility by injection of rabbits with peptides corresponding to NS 
AA 1-20, and NS AA 21-40 synthesized on a Multiple Antigen Peptide System (MAPS), 
monoclonal antibody 4F2 against reovirus T3D 3. Secondary antibodies used in 
immunofluorescence experiments are as follows: Alexa 594-conjugated goat -mouse IgG 
antibodies, Alexa 488-conjugated goat -rabbit IgG antibodies (Invitrogen),  
Virions and plasmids. Purified MRV stocks (T1L, T3D) in our laboratory were originally 
obtained from Dr. Max Nibert at Harvard University. Purified virions were prepared as 
described (8) and stored in dialysis buffer (150 mM NaCl; 10 mM Tris pH 7.4; 10 mM 
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MgCl2) at 4 °C. 10 plsmids containing each gene from MRV T1L strain (pT7L1T1L, 
pT7L2T1L, pT7L3T1L, pT7M1T1L, pT7M2T1L, pT7M3T1L, pT7S1T1L, pT7S2T1L, 
pT7S3T1L, pT7S4T1L) were made by Dr. Cathy Miller in Dr. Max Nibert’s lab. The 
backbone of these plasmids is pCI-neo (promega) which was removed of CMV promoter and 
replaced with bacteriophage T7 promotor. Viral genes from MRV T1L strain were cloned 
into this modified pCI-neo plasmid, flanked by T7 promoter at 5’ terminus of viral gene and 
by Hepatitis delta ribozyme functional domain at 3’ terminus of the viral sequence, which 
make sure intact viral RNA can be generated by T7 polymerase. 10 plasmids for each gene 
from MRV T3D strain (pT7L1T3D, pT7L2T3D, pT7L3T3D, pT7M1T3D, pT7M2T3D, 
pT7M3T3D, pT7S1T3D, pT7S2T3D, pT7S3T3D, pT7S4T3D) were obtained from Dr. Terry 
Dermody’s lab (19). Plasmids used for making inducible L929 cell line were made as 
follows: Plasmids (pFRT/LacZ, pcDNA6/TR, pOD44, pcDNA5/FRT/TO) were purchased 
from Invitrogen.  The M3 gene (from MRV strain T1L) was PCR amplified from plasmid 
pCI-neo-M3 with primers containing Hind III and BamHI sites, and was cloned into 
HindIII/BamHI digested pcDNA5/FRT/TO to make a NS inducible expression plasmid 
(pcDNA5/FRT/TO-M3).  Each of the remaining MRV genes were also PCR amplified with 
restriction enzyme-containing primers and individually cloned into pcDNA5/FRT/TO. 
Plasmid transfection and viral infection.  4.0 × 10
5
 BHK-T7 cells were seeded onto 35mm 
6-well plates the day before transfection. 10 plasmids were mixed at different concentrations 
[L genes (2 g/each), M genes (1.75 g/each), and S genes (1.5 g/each)]. BHK-T7 cells 
were co-transfected with 10 plasmids using 2 L of TransIT-LT1 transfection reagent 
(Mirus) per microgram of plasmid DNA. Four days later, transfected cells and media were 
harvested and recombinant virus was isolated using plaque assay as previously described 
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(15). Plaques were picked and virus was propagated by growth in L929 cells. Cos-7 cells 
were overlayed with rescued MRV viruses from infected L929 cell lysates, virus was 
adsorbed to cells for 1 h, at which point, cells were refed with DMEM and incubated at 37°C 
for 24 h for immunostaining to test viral phenotypes. 
RT-PCR. Total RNA extracted from infected L929 cells with wildtype (T1L, T3D) or 
rescued viruses were used as templates, and sequences of primers were used for PCR 
amplification of the M1 gene as shown in the table 1. RT-PCR was performed as described in 
the manual of Superscript III transcriptase
®
with platinum
®
 Taq HiFi kit (Invitrogen). RT-
PCR products were sequenced by the Iowa State University DNA facility. 
Extraction of viral genomic dsRNA and electropherotyping of MRV dsRNA segments. 
3×10
5
 L929 cells were infected with rescued viruses or wildtype T1L and T3D strains. At 24 
h p.i., total RNA was extracted from infected cells with TRIzol
®
 reagent (Invitrogen) per the 
manual instructions. RNA mixed with 5 × loading buffer (50% sucrose, 0.25% bromophenol 
blue, 0.25% xylene cyanol) was preheated at 60°C for 5 min, and separated on an 8% TBE 
polyacrylamide gel (15 ml H2O, 5 mL 5 × TBE, 5 mL 40% acrylamide (37.5 : 1), 30 L 
TEMED, and 300 L 10% APS) at 60 V for 14 h in 1 × TBE (10.8 g Tris, 5.5g boric acid, 40 
mL 0.5M EDTA, pH8.0).  Gels were stained in ethidium bromide (EB) buffer for 2 h and 
dsRNA segments were visualized by UV transillumination. Images were obtained using a 
Chemi-doc XRS imaging system (Bio-rad).  
Immunofluorescence (IF) assay. Cells were fixed at room temperature for 10 min with 2% 
paraformaldehyde in PBS buffer (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4 (pH 7.5)) and 
then washed three times with PBS. Fixed cells were permeabilized by incubation with 0.2% 
Triton X-100 in PBS for 5 min and then washed three times with PBS. Samples were blocked 
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by a 10 min incubation with 2% bovine serum albumin in PBS. Primary and secondary 
antibodies were diluted in 2% bovine serum albumin in PBS. After blocking, cells were 
incubated for 1 hour with primary antibodies, washed three times with PBS, and then 
incubated for another hour with secondary antibodies. Immunostained cells were washed for 
a final three times with PBS, and mounted on slides with Prolong reagent with or without 
DAPI (Invitrogen). Immunostained samples were examined with a Zeiss Axiovert 200 
inverted microscope equipped with fluorescence optics. Images were prepared by using 
Photoshop and Illustrator software (Adobe Systems). 
Establishment of inducible L929 cell lines expressing viral proteins. The Flp-In
TM
-T-
REx
TM
 Core Kit (Cat No. K6500-01, Invitrogen) was utilized to generate cell lines 
expressing reovirus proteins. Four plasmids (pFRT/LacZ, pcDNA6/TR, pOD44, 
pcDNA5/FRT/TO-M3) were used to generate an inducible L929 cell line expressing viral 
protein NS (encoded by M3).  First, L929 cells were transfected with linearized plasmid 
pFRT/LacZ and incubated for 48 hours, then split into 9-cm cell culture petri dishes. This 
plasmid is expected to randomly integrate into genomic DNA, providing the Flip 
Recombinase Target integration site for the M3 expressing plasmid (pcDNA5/FRT/TO-M3). 
Zeocin (400 g/mL) was added to dishes to select for zeocin-resistant cell colonies for two 
weeks until cells containing the pFRT/LacZ plasmid formed visible cell colonies. These 
colonies were isolated with sterile cloning cylinders and grown in individual 3.5 cm 6-well 
cell culture plates. Harvested zeocin-resistant colonies were individually tested to confirm 
integration of the plasmid pFRT/LacZ into an active transcription site with a -Gal staining 
kit (Cat No. K1465-01, Invitrogen). PCR was also used to amplify the LacZ and Zeocin-
resistant genes to further confirm that isolated cell lines contained this plasmid. pFRT/LacZ 
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containing cell lines were then transfected with the pcDNA6/TR plasmid and grown in the 
presence of blasticidin (10 g/mL) to select blasticidin-resistant cell colonies. This plasmid 
randomly integrates into genomic DNA and constitutively expresses the tetracycline 
repressor, which can bind to the tetracycline operator and inhibit the expression of M3 in 
pcDNA5/FRT/TO-M3. PCR was used to amplify the blasticidin resistant gene to confirm 
blasticidin-resistant cell colonies contain plasmid pcDNA6/TR.  Finally, pcDNA5/FRT/TO-
M3 and pOD44 were co-transfected into the confirmed zeocin and blasticidin-resistant cell 
line (L929-FRT/LacZ-DNA6/TR). Hygromycin B (500 g/mL) was added to select cell 
colonies containing pcDNA5/FRT/TO-M3. To confirm integration of pcDNA5/FRT/TO-M3 
into the FRT site in the cellular genomic DNA, a -Gal staining kit was used to assess the 
loss of LacZ. Additionally, final cell lines were examined to see if they express NS in 
response to doxycycline induction by immunofluorescence microscopy.  
Results 
Recapitulation of a plasmid based reverse genetics system for MRV. The 10 plasmid-
based reverse genetics system was originally reported by Kaboyashi et al (19, 22). The T3D 
viral cDNA segments were cloned into a vector as previously described (Figure 1A) and the 
T1L viral cDNA segments were cloned into the pCI-neo vector using a similar strategy (data 
not shown). Recombinant virus was rescued from cell transfected with each of the 10 T3D or 
T1L plasmids as shown in Figure 1B.  10 plasmids from strain T1L, 10 plasmids from strain 
T3D, or 2 plasmids from T1L (pT7S1T1L, pT7M1T1L) and 8 plasmids from T3D 
(pT7L1T3D, pT7L2T3D, pT7L3T3D, pT7M2T3D, pT7M3T3D, pT7S2T3D, pT7S3T3D, 
pT7S4T3D) were co-transfected into BHK-T7 cells respectively. At 96-hour post-
transfection, samples were harvested and recombinant virus was selected following plaque 
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assay on L929 cells. Isolated plaques containing rescued virus were harvested and grown in 
L929 cells. To confirm that we had isolated recombinant T1L virus, RNAs from rescued and 
wildtype T1L- and T3D-infected cells were used as templates to amplify the M1 gene 
segment (from nucleotides 1767-2304) with RT-PCR (Fig 2A). A mutation (T to C, top 
strand; A to G, bottom strand) at position 2173 was previously introduced in the M1 cDNA 
of the plasmid pT7M1T1L to allow discrimination between recombinant and wild-type virus.  
Sequencing results confirmed that the M1 gene from the rescued recombinant T1L virus 
contained the introduced mutation at nucleotide 2173, while the wildtype T1L M1 gene did 
not contain this mutation (Fig 2B).  To confirm that we had rescued the T3D/8,T1L S1/M1 
recombinant reassortant virus, we additionally separated viral dsRNA segments extracted 
from rescued recombinant and wildtype viruses on a TBE polyacrylamide gel. These 
electropherotyping results showed that the band patterns of dsRNA segments of rescued 
viruses from T1L plasmids, T3D plasmids, or from T3D/8, T1L S1/M1 matched up with the 
patterns of wildtype T1L and T3D viruses as expected (Fig 2C). We further examined the 3 
phenotype of recombinant virus (T3D/8, T1LS1/M1) by immunofluorescence assay utilizing 
a monoclonal antibody (4F2) that specifically recognizes T3D 3, but does not cross-react 
with T1L 3. These results further confirmed that the rescued virus (T3D/8, T1LS1/M1) 
contained T3D 3 (Fig 2D). Taken together, these assays ruled out the possibility that the 
rescued viruses came from contamination of cells from wildtype lab strains of virus and 
confirmed that we were able to repeat this complex assay using our plasmids and cell lines. 
Establishment of inducible cell lines expressing reovirus proteins. In order to rescue 
viruses that contain mutations in the genome that impede viral replication, cell lines 
expressing the corresponding proteins must be created to complement the effects of the lethal 
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mutations. In addition, because the constitutive expression of some viral proteins may be 
lethal to cells, the expression of viral proteins in these cell lines need to be inducible. To 
create cell lines that inducibly express reovirus proteins, we took advantage of the Flp-In
TM
-
T-REx
TM
 system from Invitrogen.  The overall strategy for creation of these cell lines is 
outlined in Figure 3.  First, L929 cells were transfected with plasmid pFRT/LacZ, which 
integrates into the genome of the cell resulting in a genomic copy of the Flip Recombinant 
target site fused in frame with lacZ in the cells. Cell colonies that were resistant to zeocin 
were selected and amplified. To confirm that the isolated zeocin-resistant cell colonies 
contained the pFRT/LacZ plasmid integrated in the genome, cells were fixed with 2% 
paraformaldehyde and incubated with the substrate for -Gal, and examined for blue color 
(Fig 4A). These results suggest pFRT/LacZ is integrated into a transcriptionally active site in 
the genome.  In addition, we performed RT-PCR on RNA isolated from these cell lines using 
primers specific for genes encoding LacZ and zeocin-resistance.  PCR results indicated that 
isolated zeocin-resistant cell colonies (7, 8, 10, and 20) contained LacZ and zeocin-resistance 
genes while L929 cells did not (Fig 4B). Cell colonies containing plasmid pFRT/LacZ were 
named Flp-in L929 cells. In a second step, Flp-in L929 cell line number 7 was randomly 
chosen and transfected with plasmid pcDNA6/TR, which contains the blastacidin resistance 
gene, and constitutively expresses the tetracycline repressor. RNA from twenty-three 
blasticidin-resistant cell colonies was isolated and examined by PCR for the presence of the 
blastacidin-resistance gene. Fifteen of the tested cell colonies were positive for the 
blasticidin-resistance gene (1, 2, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 23), however, 
surpisingly, 8 of them were negative for this gene (3, 19, 20, 21, 22, 24, 25, 26) (Fig 4C). 
This suggests that some cells are able to gain resistance to blasticidin without receiving the 
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pcDNA6/TR plasmid. The blasticidin-resistant cell colonies containing pcDNA6/TR and 
pFRT/LacZ were named L929-FRT-DNA6. In a final step, L929-FRT-DNA6 cell line 
number 2 was randomly chosen and co-transfected with NS expression plasmid 
pcDNA5/FRT/TO-M3 and the FRT recombinase expressing plasmid pOD44. Hygromycin B 
was used to screen for cell colonies in which pcDNA5/FRT/TO-M3 integrated within the 
previously introduced FRT site in the cellular genome. Hygromycin B-resistant cell colonies 
were then tested for their ability to inducibly express NS in the presence, but not the 
absence of doxycycline (an analog of tetracycline) by immunofluorescence microscopy (Fig 
4D).  In these experiments, cell lines were identified that inducibly express NS, suggesting 
that we had successfully established an inducible NS expressing cell line.   In addition, 
because the L929-FRT-DNA6 cell line has an integrated FRT site, this line can easily serve 
as a platform to construct isogenic inducible cell lines that express each of the other nine 
viral proteins. To this end, we have also cloned each of the reovirus genes into the 
pcDNA5/FRT/TO plasmid for the construction of each of these cell lines. 
Discussion 
Future applications of the reverse genetics system and inducible cell lines. The 10 
plasmid-based reverse genetics system for reovirus is a very powerful tool to study the 
functional role of viral genes (19). In order to study the functional role of critical proteins, 
such as NS, or to make otherwise potentially lethal mutations in the virus, inducible cell 
lines are required to complement the function of deficient proteins generated by 
mutations/deletion with this reverse genetics system. For example, the viral nonstructural 
protein NS plays an essential role in the viral replication cycle and knockout of NS results 
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in the failure of viral replication (20). In reovirus-infected cells, the NS C-terminal domain 
forms non-membranous structures in the cytoplasm (5) and the N-terminal region plays roles 
in recruitment other viral proteins ( 2, 3, NS, 2, 1, 2, 3, and core particles) (6, 21, 
27-29). With the plasmid-based reverse genetics system and inducible NS expressing cell 
line, we can generate virions containing mutation or deletions in the M3 gene (encoding 
NS) to further examine functional roles of the cytoplasmic matrix formed by the C-terminus 
of NS, and how interactions between NS and other viral proteins affect viral replication, 
translation and assembly. Additionally, we recently found that MRV infection disrupts stress 
granules (SGs) and prevents SG formation induced by sodium arsenite at late times post-
infection. Based on colocalization of NS with SGs (data not shown) and the fact that both 
NS formed viral factories and SGs are associated with microtubule network (18, 24, 33), we 
have hypothesized that NS plays a role in the disruption or prevention of SG formation.  
Using the reverse genetics system and the NS inducible cell line, we can rescue viral 
particles that contain deletions or mutations in the microtubule associated region of NS, or 
the SG-associated region of NS to test if microtubule or SG association is a factor in SG 
disruption.  
The reverse genetics system and its implication in viral translation regulation. So far, 
the efficiency of the plasmid-based reverse genetic systems is not very high. The efficiency 
of the 10-plasmid reverse genetics system is about 100 pfu/ml at 96 hours post transfection 
(19), and the improved 4 plasmid reverse genetics system only increases the efficiency to 
10
4-5 
pfu/ ml after 96 hours post-transfection (22). Both biochemical and structural analysis 
has shown that reovirus genomic plus-RNAs and mRNAs generated by core particles are 
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capped (13, 16, 17, 38).  Ribosome binding to reovirus mRNA in protein synthesis requires 5' 
terminal 7-methylguanosine (m7G) in an in vitro translation system in wheat germ extracts 
(4). Some studies have suggested viral mRNAs may not be capped at late times post-
infection (39, 42), however, this idea is not widely accepted within the field.  The 
clarification of whether capping is required for the translation of viral mRNA at late time 
infection is a critical step towards understanding the mechanism behind viral translational 
escape from host cellular shut off by eIF2  phosphorylation for all members of the 
Reoviridae family. The 10-plasmid based reverse genetics system and improved 4-plamid 
reverse genetics developed by Kobayashi and his colleagues did not address the question of 
whether the founder viral mRNAs transcribed from cDNA plasmids by T7 polymerase are 
capped (19, 22). In this reverse genetics system, presumably, T7 polymerase transcribes viral 
mRNA from cDNA plasmids in the cytoplasm, transcripts are translated into viral proteins by 
cellular translational machinery in the cytoplasm, and then translated viral proteins including 
viral transcriptase ( 3), triphosphatase ( 2), methyltransferase and guanylytransferase ( 2) 
may launch another round of viral mRNA synthesis in the cytoplasm. If first round founder 
viral mRNAs are not capped, uncapped transcripts must be translated at a low efficiency 
through some unknown mechanism different from the mechanism used by capped eukaryotic 
mRNA. If capping is required for the translation of viral mRNA, there are two possibilities. 
First, uncapped founder mRNAs transcribed by T7 polymerase are transported into the 
nucleus and capped by cellular capping enzymes in the nucleus at a very low efficiency. It is 
extremely unlikely that the T7 polymerase C-terminal domain (CTD) can recruit capping 
enzymes in the nucleus, because unlike eukaryotic polymerase II, a T7 polymerase fused 
with a eukaryotic CTD cannot recruit capping enzymes (14, 31). Second, a small amount of 
146 
 
 
 
cDNA plasmids may enter the nucleus during transfection and capped viral mRNAs may be 
generated by the cellular polymerase II and cellular capping enzymes at a very low 
efficiency, at which point, capped viral mRNAs are then transported to the cytoplasm for 
viral protein synthesis.  
Like the Reoviridae, in Birnaviruses such as IBDV, dsRNAs are protected within the 
particles throughout the virus cycle. Viral particles carry out several enzymatic activities  to 
synthesize viral mRNAs with cap structures at 5’ termini but no poly (A) tail (9). A recent 
study showed that use of a polymerase II reverse genetics system significantly improved the 
efficiency of rescuing viruses compared with previously reported T7 polymerase-based 
reverse genetics system because the polymerase II based system increases the expression of 
viral proteins which pave the way for second round of viral replication (2). Pre-transfection 
of a plasmid encoding the viral polyprotein also significantly increased the efficiency of T7 
polymerase-based reverse genetics system (2). This suggested that mRNA capping is 
required for the viral translation of IBDV. In order to answer the question of whether the 
founder viral mRNAs are capped during viral transcription in the reovirus reverse genetics 
system, we can potentially co-transfect several polymerase II-based plasmids encoding the 
viral transcription apparatus to see if this strategy improves the efficiency of rescuing viruses. 
In addition, because Lys-190 and Asp-191 are the only amino acids necessary for 2 
guanylyltransferase activity and the methyltransferase domains of 2 are known (25, 26), we 
can mutate the methyltransferase and guanylyltransferase domains of the reovirus 2 to 
determine if capping activity is required for reverse genetics.  If mRNA capping is required 
for viral translation, we could use a polymerase II based reverse genetics system to rescue 
viruses, which may be more efficient than the current T7 polymerase based reverse genetics 
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system. 
Future plans to determine the mechanism of viral translation in the presence of 
increased levels of eIF2  phosphorylation with the plasmid-based reverse genetics 
system. We have recently found that reovirus translation escape from cellular shutoff occurs 
in the presence of eIF2  phosphorylation at late times post infection as described in the 
chapter 4. Our results suggest that viral translation escape from cellular shutoff correlates 
with the disruption of SGs, and reovirus likely utilizes a unique translation mechanism to 
translate viral proteins in the presence of a limited amount of ternary complex (eIF2-GTP-
tRNAi
Met
). Different viruses have evolved different strategies in order to translate viral 
proteins in the presence of high levels of eIF2  phosphorylation (37, 40, 41). For example, 
the translation initiation of subgenomic mRNA (26S) from Sindbis viruses is not affected 
when eIF2  is phosphorylated in the presence of sodium arsenite. Genetic data suggest that a 
highly stable hairpin loop downstream of start codon (AUG) is necessary to provide 
resistance to eIF2  phosphorylation (37, 41)  In addition to the conventional eukaryotic 
eIF2- and eIF5-dependent pathway of 80S complex assembly, the hepatitis C virus (HCV) 
internal ribosome entry site (IRES) can direct the assembly of 80S translation initiation 
complexes without eIF2 and eIF5 when eIF2  is inactivated by phosphorylation under stress 
conditions or treatment of IFN  (35, 40). Bacteria have three translation initiation factors: 
IF1, IF2 and IF3; their counterparts in eukaryotic cells are eIF1A, eIF5B and eIF1 (1). Like 
bacteria, HCV only uses the minimum of translation factors under certain conditions. Only 
eIF3 and eIF5B ( the analog of bacterial IF2), are required for the assembly of HCV 
translation initiation complex (40), suggesting the origin of eIF2 in evolution is relevant to 
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the appearance of ribosomal scanning in eukaryotes as HCV translation initiation does not 
need ribosomal scanning.  Reovirus genomic RNA segments have very short 5’ UTRs of 
about 12-32 nucleotides (nts) in length (32). 40S ribosomes protect the entire stretch from the 
cap to the initiation codon, while the 80S complexes protect ~30 nts which are closer to the 
initiation codon (23). Our studies have shown that the helicase eIF4A is not required for 
MRV translation. These data strongly suggest that the assembly of the 80S translation 
initiation complex for reovirus mRNA may not require ribosomal scanning, and possibly 
does not require eIF2.  If this is the case, reovirus must use an eIF2 independent-pathway for 
viral translation at late times post-infection when host cellular translation is shut off by eIF2  
phosphorylation. 
We intend to use plasmid-based reverse genetics to examine whether a unique 
sequence in the reovirus genome or any viral proteins are required for viral translation in the 
presence of high levels of phosphorylated eIF2 . First, we will test if a unique 5’ terminal 
sequence is required for viral protein expression in the presence of phosphorylated eIF2 . A 
number of plasmids have been created or will be created (Fig 5), including: A) CMV-26S-
GFP, a positive control GFP RNA that contains the 26S enhancer region from Semliki Forest 
viruses as previously described (41); B) CMVGFP, a negative control, representing a cellular 
mRNA, which expresses a GFP mRNA that contains a cap structure and poly (A) tail; C) 
CMV-5’-S3-GFP-S3/3’, an S3GFPS3 fusion that has GFP inserted into a full length S3 gene 
and will express an S3/GFP/S3 fusion RNA containing a cap structure and poly (A) tail; D) 
CMV-GFP-HD, a control that expresses GFP RNA containing a cap structure, but not a poly 
(A) tail; E) CMV-5’S3GFPS3/3’HD, which expresses S3GFPS3 RNA containing a cap 
structure, but not a poly (A) tail; F) CMV-HR-5’-GFP-3’-HD, which express GFP without a 
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cap structure or poly (A) tail. G) CMV HRS3GFPS3HD, which expresses S3GFPS3 RNA 
without a cap structure or poly (A) tail. HR represents the hammerhead ribozyme which 
cleaves newly synthesized mRNA at its 5’ terminus, HD represents hepatitis delta virus 
ribozyme which cleaves newly synthesized mRNA at its 3’ terminus. We will first examine 
the expression of the proteins encoded by these constructs in transfected cells in the presence 
of phosphorylated eIF2 .  Once we identify a sequence or structure necessary for translation 
of reovirus mRNA, we will then examine the importance of that region in viral mRNA 
translation by creating viruses in which these regions are mutated using the reverse genetics 
system.  In addition, we will also examine the role played by individual virus proteins in 
translation of viral mRNA in the presence of phosphorylated eIF2  by generating reverse 
genetics viruses that do not express individual viral proteins. Each of these approaches using 
the reverse genetics systems should reveal important information on how reovirus translation 
escapes phospho-eIF2  induced host translational shutoff. 
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Fig 1. The MRV 10-plasmid-based reverse genetics system. A. Construction of reverse 
genetics plasmids. Viral cDNAs are fused at their native 5’ termini to the bacteriophage T7 
RNA polymerase promoter, and fused at their native 3’ termini to the Hepatitis Delta virus 
(HDV) ribozyme sequence. B. Schematic of approach. The ten reovirus cDNA contructs are 
transfected into BHK cells which constitutively express T7 polymerase. Nascent viral 
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mRNAs generated by T7 polymerase correspond to the native 5’ termini. The native 3’ 
termini are generated by self-cleavage by the HDV ribozyme. At 4 days post-transfection, 
transfected cells are lysed, subjected to three cycles of freeze/thawing, and viable virus is 
rescued from the cloned cDNA containing plasmids by plaque assay using L929 cells. 
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Fig 2. Characterization of reovirus rescued from 10-plasmid based reverse genetics 
system. A. RT-PCR for partial M1 gene sequences (1767-2304) from rescued viruses (T1L 
RG), wildtype T1L viruses (wt T1L) and plasmid pT7M1(T1L).  B. Sequencing of the partial 
M1 sequences (1767-2304) from wt T1L, rescued viruses T1L RG, and plasmid pT7M1 
(T1L). Both forward and reverse sequencing indicate the M1 gene from wt T1L viruses has 
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an A (T) at position 2173, while the M1 gene from rescued T1L viruses has a G (C) at this 
position similar to that seen in plasmid pT7M1(T1L). C. Electropherotypes of dsRNA from 
wildtype T1L, T1L recombinant, recombinant virus (T3D/8, T1L S1/M1), T3D recombinant, 
and wildtype T3D. Viral dsRNA was extracted from infected Cos-7 cells with TRIzol and 
separated on an SDS-polyacrylamide gel, followed by ethidium bromide staining to visualize 
viral gene segments. Gene segments are indicated. D. Immunoflurorescence staining of 
wildtype T3D, wildtype T1L, and rescued recombinant virus (T3D/8, T1LS1/M1). Infected 
Cos-7 cells were immunostained with mouse monoclonal antibody 4F2 against viral protein 
3 and rabbit anti- NS polyclonal antibodies, followed by secondary goat anti-mouse IgG 
conjugated with Alexa 594 and goat anti-rabbit IgG conjugated with Alexa 488. Scale bar = 
10 m. 
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Fig 3. Schematic for establishing an inducible L929 cell line expressing viral 
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nonstructural protein NS. (1) L929 cells were transfected with plasmid pFRT/LacZ.  
L929 cells with plasmid pFRT/LacZ integrated into genomic DNA at a transcriptionally-
active site were selected with Zeocin (400 g/mL) and confirmed with a -Gal staining kit 
and RT-PCR. This cell line is named Flp-in-L929. (2) Flp-in-L929 line was transfected with 
plasmid pcDNA6/TR.  Cell lines containing this plasmid were selected with blasticidin (10 
g/mL), and constitutively express the tetracycline repressor.  This cell line remains resistant 
to zeocin and is named L929-FRT-DNA6/TR. (3) L929-FRT-DNA6/TR were cotransfected 
with plasmids pcDNA5/FRT/TO-M3 and pOD44.  Cell lines resistant to hygromycin B were 
selected.  These lines selectively express NS in the presence of doxycycline (2 g/mL). The 
selected cell lines were named L929-FRT-DNA6-M3. The FLP recombinase expressed by 
plasmid pOD44 facilitates recombination between plasmid pcDNA5/FRT/TO-M3 and 
cellular genomic DNA at the previously integrated FRT site. In the absence of doxycycline, 
an analog of tetracycline, expression of NS is inhibited by the tetracycline repressor protein 
that is constitutively expressed by the integrated plasmid pcDNA6/TR. When doxycycline is 
present, it binds to tetracycline repressor proteins and therefore prevents binding to the 
tetracycline Operator, resulting in the release of expression of NS. 
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Fig 4. Characterization of an inducible L929 cell line expressing viral protein NS. A. -
Gal staining for zeocin-selected Flp-in-L929 cell line. Zeocin-selected Flp-in-L929 cells 
were fixed with 2% paraformaldehyde and then stained with a commercially available -Gal 
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Kit (Invitrogen). -Gal positive cells are stained blue. B. Genomic DNA from selected -Gal 
positive cells and L929 cells were extracted and used as templates for PCR using primers 
specific for the amplified genes. C. Twenty-four blasticidin-resistant cell colonies were 
selected, and genomic DNAs were extracted from those cell lines as templates for amplifying 
the blasticidin resistant gene. The pcDNA6/TR plasmid was used as a positive template 
control (+).  D. L929-FRT-DNA6-M3/2 cell cells were treated with or without doxycycline 
(2 g/mL) for 48 hours and fixed with 2% paraformaldehyde. Cells were immunostained with 
rabbit anti- NS antibody, followed with Alexa 488 conjugated to goat anti-rabbit IgG.  
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Fig 5. Plasmid constructs for identification of MRV sequence or structure important for 
translation in the presence of eIF2  phosphorylation. A) CMV-S26-GFP, a positive 
control GFP RNA that contains the 26S enhancer region from Semliki Forest Virus that has 
previously been shown to escape host cell translational shutoff. B) CMVGFP, a negative 
control representing cellular mRNA, which expresses a GFP mRNA that contains a Cap 
structure and poly A tail C) CMV-5’S3-GFP-S3/3’, an MRV S3/GFP/S3 fusion that has the 
GFP gene inserted into the full length MRV S3 gene and will express an S3/GFP/S3 fusion 
RNA containing a Cap and poly A tail, D) CMVGFP-HD, a control which expresses the GFP 
gene containing a Cap, but no polyA tail E) CMV-5’S3-GFP-S3/3’-HD, an MRV S3/GFP/S3 
fusion that has the GFP gene inserted into the full length MRV S3 gene and will express an 
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S3/GFP/S3 fusion RNA with a Cap, but no poly A tail. F) CMV-HR-5’GFP-3’-HD, a control 
GFP mRNA that does not contain a Cap or a polyA tail, or G) CMV-5’-HR-S3-GFP-S3/3’-
HD, an MRV S3/GFP/S3 fusion that has the GFP gene inserted into the full length MRV S3 
fusion RNA that does not contain a Cap or poly A tail.  Constructs D-G each contain a 
Hepatitis d ribozyme sequence positioned to cleave RNAs at the exact 3’ end of the MRV or 
GFP gene.  Constructs F and G contain a hammerhead ribozyme positioned to cleave RNAs 
at the exact 5’ end of the MRV or GFP gene. Each of these RNAs will be examined for their 
ability to be translated in the presence of SA. 
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Table 1.  Primers used in the reverse genetics system and the study of establishing an 
inducible cell line expressing viral protein NS. 
Genes  Primers  
T1L M1 (1767-2304)  Forward 5'-ATGCTACTAGCGCGCAGC-3' 
  Reverse 5'-GATGAAGCGCGTACGTAGTCTTAG-3' 
Zeocin resistant gene  Forward 5'-CCAAGTTGACCAGTGCCG-3' 
  Reverse 5'-TCAGTCCTGCTCCTCGGC-3' 
LacZ gene  Forward 5'-GCCGTCGTTTTACAACGT-3' 
  Reverse 5'-ACAACCCGTCGGATTCTC-3' 
Blasticidin resistant gene   Forward 5’-AACCATGGCCAAGCCTTTG-3' 
  Reverse 5'-TTAGCCCTCCCACACATAA-3' 
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CHAPTER 6. GENERAL CONCLUSIONS 
       In this project, we first described that infection of mammalian orthoreovirus leads to an 
stress granule formation, following viral uncoating, but preceding viral transcription or 
translation at early times post-infection (2-6h. p.i.).  MRV induction of SGs was found to be 
triggered by increased levels of phosphorylated eIF2  activated by at least two kinases 
(PKR, PERK, GCN, HRI).  However, though eIF2  phosphorylation was maintained 
throughout infection, SGs were not observed in MRV-infected cells at late times post-
infection, suggesting that SG formation is unlikely to be involved in shutting off cellular 
translation following MRV infection at late times post-infection as previously proposed. We 
further found that viral gene expression renders cells unable to form SGs in response to 
external stress signaling, and that this interference is downstream of eIF2 phosphorylation. 
The mechanism for MRV disruption of SGs is not yet determined and will be an important 
avenue of future study.  
       SGs hold cellular translation in check and only allow the expression of stress response 
genes, determining whether cells will be destined for apoptosis or recovery from stress. In 
our study, we showed viral particles are recruited into SGs following virus entry into the 
cytoplasm in a manner dependent on newly synthesized viral mRNAs. Viral translation 
correlates with the disruption of SGs. Cellular, but not viral, translation is inhibited by 
increased levels of eIF2  phosphorylation seen following MRV infection or treatment with 
sodium arsenite, as well as inhibition of eIF4A, suggesting MRV uses a unique translational 
initiation mechanism which does not require, or is at least less dependent on ternary complex 
(eIF2-GTP-tRNAi
Met
) and eIF4A for initiation. We further showed MRV translation is not 
inhibited in the presence of eIF2  phosphorylation in the PKR-/- MEF cell line, which 
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directly demonstrated that viral translation escape from host translational shutoff is not 
through viral protein 3 inhibition of PKR in the vicinity of viral translation as previously 
proposed.  This represents the first evidence that MRV induction of host cell translational 
shutoff, and MRV escape from translational shutoff are independent mechanisms.  This has 
laid important groundwork for future studies identifying the mechanism of MRV translation 
initiation in the presence of limited ternary complex. 
       Hypoxia is a common feature of malignant tumors where tumors rapidly outgrow their 
vascular supply and develop hypoxic microenvironments. Hypoxia induces phosphorylation 
of eIF2  leading to the formation of stress granules (SGs), which likely contributes to the 
resistance of hypoxic cells to apoptosis induced by cancer therapeutics. Our studies found 
that MRV infection actively disrupts SGs and successfully translate viral proteins in the 
presence of phosphorylated eIF2 These findings enhance our understanding of the 
mechanisms behind MRV escape from cellular translational inhibition in the presence of 
eIF2  phosphrylation when cells are treated with IFN, X-ray, genotoxic drugs, and will lead 
to important future studies impacting our understanding of the mechanisms behind MRV 
oncolysis of tumor cells. 
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